Optimized tissue-preferred promoter and uses thereof

ABSTRACT

The present disclosure provides the identification of promoters that are preferentially active in tobacco axillary buds. Also provided are tobacco plants comprising reduced or no sucker growth. Also provided are methods and compositions for producing tobacco plants comprising reduced or no sucker growth.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 16/529,365, filed Aug. 1, 2019, which claims the benefit under 35 U.S.C. § 119 of U.S. Provisional Application No. 62/713,819, filed Aug. 2, 2018, both of which are herein incorporated by reference in its entirety their entireties.

FIELD

The present disclosure provides methods and compositions for refining the expression of nucleic acids and proteins useful for the reduction or elimination of suckers in plants.

INCORPORATION OF SEQUENCE LISTING

A sequence listing contained in the file named “P34633US02 SL.TXT″ which is 733,459 bytes (measured in MS-Windows®) and created on Feb. 28, 2022 is filed electronically herewith and incorporated by reference in its entirety.

BACKGROUND

Tobacco is a plant species that exhibits exceptionally strong apical dominance. Molecular signals from the shoot apical meristem (SAM) mediate a hormonal signal that effectively inhibits axillary bud growth. Upon removal of the SAM (also known as “topping”), physiological and molecular changes occur, enabling the growth of new shoots (or “suckers”) from axillary meristems (buds). Sucker growth results in loss of yield and leaf quality. Suckers have been controlled by manual removal and through the application of chemicals. Maleic hydrazide and flumetralin are routinely used on topped plants to inhibit axillary bud growth (“suckering”). However, labor and chemical agents to control suckers are very expensive. Control of suckering in tobacco through conventional breeding, mutation breeding, and transgenic approaches have been a major objective for several decades but, to date, successful inhibition or elimination of suckering has not been achieved through these approaches. Recent molecular work has produced transgenic plants with reduced or eliminated suckers, but leaky expression of axillary bud-degrading genes can result in the death of seeds and embryos and prevents the production of successive generations of transgenic plants. Therefore, development of methods and compositions to prevent axillary bud-degrading genes from being expressed in non-desired tissues and/or organs would result in a reduction of the use of chemical agents and would reduce costs and labor associated with tobacco production.

SUMMARY

In one aspect, this disclosure provides a nucleic acid molecule comprising a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule.

In one aspect, this disclosure provides a tobacco plant comprising a nucleic acid molecule comprising a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule, where the tobacco plant comprises no suckers or reduced suckers after topping as compared to a control tobacco plant of the same variety when grown under comparable conditions.

In one aspect, this disclosure provides a plant or seed comprising a nucleic acid molecule, where the nucleic acid molecule comprises a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule encoding an axillary bud-degrading product.

In one aspect, this disclosure provides a method for controlling topping-induced suckers in a tobacco plant comprising: (a) introducing a nucleic acid molecule to a tobacco cell, wherein said nucleic acid molecule comprises a promoter active in axillary bud tissue, where the promoter: (i) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (ii) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (iii) is operably linked to a heterologous nucleic acid molecule encoding an axillary bud-degrading product; and (b) regenerating a tobacco plant from said tobacco cell, where the tobacco plant comprises no or reduced topping-induced suckers as compared to a control tobacco plant grown under comparable conditions.

In one aspect, this disclosure provides a method of growing a tobacco plant comprising planting a tobacco seed comprising a nucleic acid molecule, where the nucleic acid molecule comprises a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule encoding an axillary bud-degrading product, where the tobacco seed germinates into a tobacco plant comprising no or reduced topping-induced suckers as compared to a control tobacco plant grown under comparable conditions.

BRIEF DESCRIPTION OF THE SEQUENCES

SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45, 47, 49, 51, 53, 55, 57, 59, 61, 63, 65, 67, 69, 71, 73, 75, 77, 79, 81, 83-160, 186, 188, 190, 192, 194, 196, 198, 200, 202, 204, 205, 207, 209, 211, 213, 215, 217, 219, 221, 223, 225-228, 230, 232, 234, 236, 238, 240, 242, 244, 246, 248, 250, 252, 254, and 257-260 are nucleic acid sequences.

SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 56, 58, 60, 62, 64, 66, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, 255, and 256 are polypeptide sequences.

Additional descriptions of the SEQ ID NOs provided herein can be found in Table 1.

TABLE 1 Description of sequences SEQ Sequence NCBI Accession Number of the ID NO Type Sequence Description Top Hit of A BLAST Search 1 Nucleic Transcription factor CYCLOIDEA-like XM_009609861.1 Acid 2 Peptide Transcription factor CYCLOIDEA-like 3 Nucleic Flower-specific gamma-thionin P32026.1 Acid 4 Peptide Flower-specific gamma-thionin 5 Nucleic Polyphenoloxidase XP_006347083.1 Acid 6 Peptide Polyphenoloxidase 7 Nucleic UDP-glucose:glucosyltransferase BAG80546.1 Acid 8 Peptide UDP-glucose:glucosyltransferase 9 Nucleic Tumor-related protein BAA05479.1 Acid 10 Peptide Tumor-related protein 11 Nucleic Hypothetical protein CAN66732.1 Acid 12 Peptide Hypothetical protein 13 Nucleic TCP1 protein-like gene FJ194953.1 Acid 14 Peptide TCP1 protein-like gene 15 Nucleic Chlorophyllase-2 EYU43828.1 Acid 16 Peptide Chlorophyllase-2 17 Nucleic AP2/ERF domain-containing XP_006363442.1 Acid transcription factor 18 Peptide AP2/ERF domain-containing transcription factor 19 Nucleic Putative miraculin XP_006360306.1 Acid 20 Peptide Putative miraculin 21 Nucleic Oleosin XP_004236249.1 Acid 22 Peptide Oleosin 23 Nucleic ACC synthase XP_006356827.1 Acid 24 Peptide ACC synthase 25 Nucleic LOB domain-containing protein 18-like XP_007052037.1 Acid 26 Peptide LOB domain-containing protein 18-like 27 Nucleic Vicilin-like antimicrobial peptides XP_006363154.1 Acid cupin super family 28 Peptide Vicilin-like antimicrobial peptides cupin super family 29 Nucleic Abscisic acid insensitive XP_006341248.1 Acid 30 Peptide Abscisic acid insensitive 31 Nucleic Seipin-like XP_004237589.1 Acid 32 Peptide Seipin-like 33 Nucleic Transcription factor CYCLOIDEA-like XM_009618194.1 Acid 34 Peptide Transcription factor CYCLOIDEA-like 35 Nucleic Transcription factor DICHOTOMA-like XM_009593876.1 Acid 36 Peptide Transcription factor DICHOTOMA-like 37 Nucleic Transcription factor CYCLOIDEA-like XM_009764845.1 Acid 38 Peptide Transcription factor CYCLOIDEA-like 39 Nucleic RING-H2 finger protein ATL11-like XP_004251547.1 Acid 40 Peptide RING-H2 finger protein ATL11-like 41 Nucleic Homeobox-leucine zipper protein XP_004232382.1 Acid ATHB-40-like 42 Peptide Homeobox-leucine zipper protein ATHB-40-like 43 Nucleic Uncharacterized protein- XP_006357617.1 Acid LOC102586855 isoform X1 44 Peptide Uncharacterized protein- LOC102586855 isoform X1 45 Nucleic Unknown CAN63006.1 Acid 46 Peptide Unknown 47 Nucleic MADS affecting flowering 5-like XP_006366525.1 Acid isoform X1/X2 48 Peptide MADS affecting flowering 5-like isoform X1/X2 49 Nucleic Nuclear transcription factor Y subunit XP_006351227.1 Acid 50 Peptide Nuclear transcription factor Y subunit 51 Nucleic Nuclear transcription factor Y subunit XP_006351229.1 Acid A-7-like 52 Peptide Nuclear transcription factor Y subunit A-7-like 53 Nucleic Transcription factor CYCLOIDEA-like XM_009767637.1 Acid 54 Peptide Transcription factor CYCLOIDEA-like 55 Nucleic Arabidopsis cytokinin oxidase NM_129714.3 Acid 56 Peptide Arabidopsis cytokinin oxidase 57 Nucleic Nicotiana tabacum cytokinin oxidase XM_009611148.1 Acid 58 Peptide Nicotiana tabacum cytokinin oxidase 59 Nucleic Nicotiana tabacum cytokinin oxidase XM_009632505.1 Acid 60 Peptide Nicotiana tabacum cytokinin oxidase 61 Nucleic Nicotiana tabacum Isopentenyl XM_009784416.1 Acid transferase gene (IPT-g120126 ) 62 Peptide Nicotiana tabacum Isopentenyl transferase gene (IPT-g120126 ) 63 Nucleic Nicotiana tabacum WUSCHEL (WUS- XM_009589135.1 Acid g151887 ) 64 Peptide Nicotiana tabacum WUSCHEL (WUS- g151887 ) 65 Nucleic Nicotiana tabacum WUSCHEL (WUS- XM_009793912.1 Acid g135280) 66 Peptide Nicotiana tabacum WUSCHEL (WUS- g135280) 67 Nucleic Arabidopsis thaliana CLAVATA3 NM_001124926.1 Acid (CLV3) 68 Peptide Arabidopsis thaliana CLAVATA3 (CLV3) 69 Nucleic Nicotiana tabacum CLAVATA3 XM_009628563.1 Acid (Scaffold00010610) 70 Peptide Nicotiana tabacum CLAVATA3 (Scaffold00010610) 71 Nucleic Nicotiana tabacum LATERAL XM_009619761.1 Acid SUPPRESSOR (g56830) 72 Peptide Nicotiana tabacum LATERAL SUPPRESSOR (g56830) 73 Nucleic Nicotiana tabacum LATERAL XM_009766770.1 Acid SUPPRESSOR (scafflod0004261) 74 Peptide Nicotiana tabacum LATERAL SUPPRESSOR (scafflod0004261) 75 Nucleic Nicotiana tabacum REGULATOR OF XM_009802273.1 Acid AXILLARY MERISTEMS (RAX- scaffold0000950) 76 Peptide Nicotiana tabacum REGULATOR OF AXILLARY MERISTEMS (RAX- scaffold0000950) 77 Nucleic Nicotiana tabacum REGULATOR OF XM_009602411.1 Acid AXILLARY MERISTEMS (RAX- scaffold00001904) 78 Peptide Nicotiana tabacum REGULATOR OF AXILLARY MERISTEMS (RAX- scaffold00001904) 79 Nucleic Bacillus amyloliquefaciens CP009748.1 Acid extracellular ribonuclease (Barnase) 80 Peptide Bacillus amyloliquefaciens extracellular ribonuclease (Barnase) 81 Nucleic Arabidopsis thaliana BRANCHED1 NM_001125184.1 Acid 82 Peptide Arabidopsis thaliana BRANCHED1 83 Nucleic RNAi_1 (targeting SEQ ID NO: 1) Acid 84 Nucleic RNAi_2 (targeting SEQ ID NO: 3) Acid 85 Nucleic RNAi_5 (targeting SEQ ID NO: 9) Acid 86 Nucleic RNAi_7 (targeting SEQ ID NO: 13) Acid 87 Nucleic RNAi_8 (targeting SEQ ID NO: 15) Acid 88 Nucleic RNAi_9 (targeting SEQ ID NO: 17) Acid 89 Nucleic RNAi_10 (targeting SEQ ID NO: 19) Acid 90 Nucleic RNAi_12 (targeting SEQ ID NO: 21) Acid 91 Nucleic RNAi_14 (targeting SEQ ID NO: 25) Acid 92 Nucleic RNAi_15 (targeting SEQ ID NO: 27) Acid 93 Nucleic RNAi_16 (targeting SEQ ID NO: 29) Acid 94 Nucleic RNAi_17 (targeting SEQ ID NO: 31) Acid 95 Nucleic RNAi_18 (targeting SEQ ID NO: 35) Acid 96 Nucleic RNAi_26 (targeting SEQ ID NO: 49) Acid 97 Nucleic RNAi_61 (targeting SEQ ID NO: 61) Acid 98 Nucleic RNAi_63 and 65 (targeting SEQ ID Acid NO: 63 and 65) 99 Nucleic RNAi_71 and 73 (targeting SEQ ID Acid NO: 71 and 73) 100 Nucleic RNAi_75 and 77 (targeting SEQ ID Acid NO: 75 and 77) 101 Nucleic RNAi_CET-26-6 (targeting SEQ ID Acid NO: 11, 49, 108, 109 and 110) 102 Nucleic RNAi_45-2-7-TDNA-145337-RI Acid (targeting SEQ ID NO: 39) 103 Nucleic RNAi_45-2-7-TDNA-348CDS-RI Acid (targeting SEQ ID NO:41) 104 Nucleic RNAi_45-2-7-TDNA-131180CDS-RI Acid (targeting SEQ ID NO: 43) 105 Nucleic RNAi_45-2-7-TDNA-22266-RI Acid (targeting SEQ ID NO: 45) 106 Nucleic RNAi_45-2-7-TDNA-53803/75660-RI Acid (targeting SEQ ID NO: 49) 107 Nucleic RNAi_45-2-7-TDNA-21860-RI Acid (targeting SEQ ID NO: 47) 108 Nucleic CEN-like protein 2 (CET2) g114109 AF145260.1 Acid 109 Nucleic CEN-like protein 2 (CET2) g2420 XM_009596199.1 Acid 110 Nucleic CEN-like protein 2 (CET2) XM_009787775.1 Acid Scaffold0003597 CDS 111 Nucleic Transformation cassette Acid 112 Nucleic Agrobacterium transformation vector Acid p45-2-7 113 Nucleic A promoter sequence of a gene Acid encoding SEQ ID NO: 2 (Gene 1) 114 Nucleic A promoter sequence of a gene Acid encoding SEQ ID NO: 8 (Gene 4) 115 Nucleic A promoter sequence of a gene Acid encoding SEQ ID NO: 14 (Gene 7) 116 Nucleic promoter of SEQ ID NO: 275 (Gene Acid 11) 117 Nucleic A promoter sequence of a gene Acid encoding SEQ ID NO: 28 (Gene 15) 118 Nucleic A promoter sequence of a gene Acid encoding SEQ ID NO: 4 (Gene 2) 119 Nucleic Sequence for TALEN donor, which Acid targets a gene encoding SEQ ID NO: 1 120 Nucleic Sequence for TALEN binding sites, Acid which targets a gene encoding SEQ ID NO: 1 121 Nucleic Sequence for TALEN, include Acid promoter NO: 118, NO: 113 which targets a gene encoding SEQ ID NO: 13 122 Nucleic Sequence for TALEN biding sites, Acid which targets a gene encoding SEQ ID NO: 13 123 Nucleic Nicotiana tabacum T2 Rnase XP_009794914.1 Acid 124 Nucleic Nicotiana tabacum T2 Rnase XP_009766067.1 Acid 125 Nucleic Nicotiana tabacum P1 Rnase XP_009597823.1 Acid 126 Nucleic Nicotiana tabacum Rnase XP_009775662.1 Acid 127 Nucleic Nicotiana tabacum T2 Rnase XM_009794797.1 Acid 128 Nucleic Nicotiana tabacum T2 Rnase XM_009627900.1 Acid 129 Nucleic Nicotiana tabacum T2 Rnase JQ041907.1 Acid 130 Nucleic Nicotiana tabacum T2 Rnase XM_009795594.1 Acid 131 Nucleic Nicotiana tabacum T2 Rnase XM_009795502.1 Acid 132 Nucleic Nicotiana tabacum T2 Rnase XM_009606804.1 Acid 133 Nucleic Nicotiana tabacum T2 Rnase XM_009794798.1 Acid 134 Nucleic Nicotiana tabacum T2 Rnase AB034638.1 Acid 135 Nucleic Nicotiana tabacum T2 Rnase XM_009784762.1 Acid 136 Nucleic Nicotiana tabacum T2 Rnase XM_009798107.1 Acid 137 Nucleic VPE14 XM_009773 063.1 Acid 138 Nucleic VPE15 XM_009594104.1 Acid 139 Nucleic VPE16 XM_009784979.1 Acid 140 Nucleic VPE17 XM_009765910.1 Acid 141 Nucleic VPE4 XM_009623321.1 Acid 142 Nucleic VPE6 XM_009764257.1 Acid 143 Nucleic VPE7 AB075949.1 Acid 144 Nucleic Nicotiana tabacum Proteinase XM_009801188.1 Acid 145 Nucleic Nicotiana tabacum Proteinase XM_009792063.1 Acid 146 Nucleic Nicotiana tabacum Proteinase XM_009779330.1 Acid 147 Nucleic Nicotiana tabacum Proteinase XM_009764284.1 Acid 148 Nucleic Thionin 5′ upstream regulatory Acid sequence 149 Nucleic Nicotiana tabacum Lateral Suppressor1 Acid (LAS1) 5′ upstream regulatory sequence 150 Nucleic Nicotiana tabacum LAS1 3′ Acid downstream regulatory sequence 151 Nucleic Nicotiana tabacum LAS2 5′ upstream Acid regulatory sequence 152 Nucleic Nicotiana tabacum LAS2 3′ Acid downstream regulatory sequence 153 Nucleic Nicotiana tabacum Regulator of Acid Axillary Meristems1 (RAX1) 5′ upstream regulatory sequence 154 Nucleic Nicotiana tabacum RAX1 3′ Acid downstream regulatory sequence 155 Nucleic Nicotiana tabacum RAX2 5′ upstream Acid regulatory sequence 156 Nucleic Nicotiana tabacum RAX2 3′ Acid downstream regulatory sequence 157 Nucleic SEQ ID NO: 27 5′ upstream regulatory Acid sequence 158 Nucleic SEQ ID NO: 27 3′ downstream Acid regulatory sequence 159 Nucleic SEQ ID NO: 27 homolog 5′ upstream Acid regulatory sequence 160 Nucleic SEQ ID NO: 27 homolog 3′ Acid downstream regulatory sequence 161 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 123 162 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 124 163 Peptide Nicotiana tabacum P1 Rnase encoded by SEQ ID NO: 125 164 Peptide Nicotiana tabacum Rnase encoded by SEQ ID NO: 126 165 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 127 166 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 128 167 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 129 168 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 130 169 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 131 170 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 132 171 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 133 172 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 134 173 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 135 174 Peptide Nicotiana tabacum T2 Rnase encoded by SEQ ID NO: 136 175 Peptide VPE14 encoded by SEQ ID NO: 137 176 Peptide VPE15 encoded by SEQ ID NO: 138 177 Peptide VPE16 encoded by SEQ ID NO: 139 178 Peptide VPE17 encoded by SEQ ID NO: 140 179 Peptide VPE4 encoded by SEQ ID NO: 141 180 Peptide VPE6 encoded by SEQ ID NO: 142 181 Peptide VPE7 encoded by SEQ ID NO: 143 182 Peptide Nicotiana tabacum Proteinase encoded by SEQ ID NO: 144 183 Peptide Nicotiana tabacum Proteinase encoded by SEQ ID NO: 145 184 Peptide Nicotiana tabacum Proteinase encoded by SEQ ID NO: 146 185 Peptide Nicotiana tabacum Proteinase encoded by SEQ ID NO: 147 186 Nucleic C12866 (Gene 11) XP_006467846.1 Acid 187 Peptide C12866 (Gene 11) 188 Nucleic Nicotiana tabacum STM homolog AB004785 Acid (NTH15) 189 Peptide Nicotiana tabacum STM homolog (NTH15) 190 Nucleic Nicotiana tabacum (Grassy Tillers1) Acid GT1 homolog 191 Peptide Nicotiana tabacum (Grassy Tillers1) GT1 homolog 192 Nucleic Arabidopsis thaliana More Axillary AK316903.1 Acid Branching1 (MAX2) 193 Peptide Arabidopsis thaliana More Axillary Branching1 (MAX2) 194 Nucleic Arabidopsis thaliana MAX2 AAK97303.1 Acid 195 Peptide Arabidopsis thaliana MAX2 196 Nucleic Nicotiana tabacum MAX2 homolog XM_009801023.1 Acid 197 Peptide Nicotiana tabacum MAX2 homolog 198 Nucleic Nicotiana tabacum MAX2 homolog XM_009625596.1 Acid 199 Peptide Nicotiana tabacum MAX2 homolog 200 Nucleic Arabidopsis thaliana Lateral BT026519.1 Acid Suppressor (LAS) 201 Peptide Arabidopsis thaliana Lateral Suppressor (LAS) 202 Nucleic Arabidopsis thaliana Regulator of AY519628.1 Acid Axillary Meristems (RAX) 203 Peptide Arabidopsis thaliana Regulator of Axillary Meristems (RAX) 204 Nucleic Regulatory region of Solanum Acid lycopersicum homolog of SEQ ID NO: 28 205 Nucleic Solanum lycopersicum homolog of HG975514.1 Acid SEQ ID NO: 28 206 Peptide Solanum lycopersicum homolog of SEQ ID NO: 28 207 Nucleic Arabidopsis thaliana ALCATRAZ Acid 208 Peptide Arabidopsis thaliana ALCATRAZ 209 Nucleic Arabidopsis thaliana VND6 Acid 210 Peptide Arabidopsis thaliana VND6 211 Nucleic Arabidopsis thaliana VND7 Acid 212 Peptide Arabidopsis thaliana VND7 213 Nucleic Solanum lycopersicum Adi3 Acid 214 Peptide Solanum lycopersicum Adi3 215 Nucleic Arabidopsis thaliana XCP1 Acid 216 Peptide Arabidopsis thaliana XCP1 217 Nucleic Arabidopsis thaliana XCP2 Acid 218 Peptide Arabidopsis thaliana XCP2 219 Nucleic Arabidopsis thaliana Metacaspase 2d Acid (ATMC4) 220 Peptide Arabidopsis thaliana Metacaspase 2d (ATMC4) 221 Nucleic Arabidopsis thaliana disease resistance Acid protein RPS5 222 Peptide Arabidopsis thaliana disease resistance protein RPS5 223 Nucleic Nicotiana tabacum TMV resistance N Acid gene 224 Peptide Nicotiana tabacum TMV resistance N gene 225 Nucleic Saccharum spp. mature miRNA159 Acid 226 Nucleic Nicotiana tabacum precursor Acid miRNA159 227 Nucleic Nicotiana tabacum mature miRNA159 Acid 228 Nucleic Nicotiana NAC089 Acid 229 Peptide Nicotiana NAC089 230 Nucleic Nicotiana BAG6 Acid 231 Peptide Nicotiana BAG6 232 Nucleic Nicotiana mitogen-activated protein Acid kinase kinase 2 (NtMEK2) 233 Peptide Nicotiana mitogen-activated protein kinase kinase 2 (NtMEK2) 234 Nucleic Arabidopsis thaliana Flavin Acid monooxygenase (YUCCA1) 235 Peptide Arabidopsis thaliana Flavin monooxygenase (YUCCA1) 236 Nucleic Arabidopsis thaliana Pin-formed1 Acid (PIN1) 237 Peptide Arabidopsis thaliana Pin-formed1 (PIN1) 238 Nucleic Arabidopsis thaliana Tryptophan Acid aminotransferase1/Transport inhibitor response2 (TAA1/TIR2) 239 Peptide Arabidopsis thaliana Tryptophan aminotransferase1/Transport inhibitor response2 (TAA1/TIR2) 240 Nucleic Arabidopsis thaliana Aldehyde Acid oxidase1 (AAO1) 241 Peptide Arabidopsis thaliana Aldehyde oxidase1 (AAO1) 242 Nucleic Arabidopsis thaliana Indole-3- Acid acetamide hydrolase1 (AMI1) 243 Peptide Arabidopsis thaliana Indole-3 - acetamide hydrolase1 (AMI1) 244 Nucleic Nicotiana Flavin monooxygenase Acid (NtYUCCA-like1) 245 Peptide Nicotiana Flavin monooxygenase (NtYUCCA-like1) 246 Nucleic Nicotiana Flavin monooxygenase Acid (NtYUCCA-like2) 247 Peptide Nicotiana Flavin monooxygenase (NtYUCCA-like2) 248 Nucleic Nicotiana Pin-formed1-like (NtPIN1- Acid like) 249 Peptide Nicotiana Pin-formed1-like (NtPIN1- like) 250 Nucleic Nicotiana Tryptophan Acid aminotransferase1/Transport inhibitor response2-like (NtTAA1/TIR2-like) 251 Peptide Nicotiana Tryptophan aminotransferase1/Transport inhibitor response2-like (NtTAA1/TIR2-like) 252 Nucleic Nicotiana Aldehyde oxidase1-like Acid (NtAAO1-like) 253 Peptide Nicotiana Aldehyde oxidase1-like (NtAAO1-like) 254 Nucleic Nicotiana Indole-3-acetamide Acid hydrolase1-like (NtAMI1-like) 255 Peptide Nicotiana Indole-3-acetamide hydrolase1-like (NtAMI1-like) 256 Peptide 6x Histidine tag 257 Nucleic Promoter SEQ ID NO: 113 comprising Acid a 100 nucleotide deletion 258 Nucleic Bud Dormancy Element Acid 259 Nucleic Sugar Repressive Element Acid 260 Nucleic Axillary Bud up2 Element Acid

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a plasmid map of binary vector p45-2-7 (SEQ ID NO: 112).

FIG. 2 depicts the location of the cis-regulatory elements Bud Dormancy Element (SEQ ID NO: 258), Sugar Repressive Element (SEQ ID NO: 259), and Axillary Bud Up2 Element (SEQ ID NO: 260) in the promoter sequences p1 2.5 kb (SEQ ID NO: 113) and p1 2.4 kb (SEQ ID NO: 257).

FIG. 3 shows the expression pattern of the promoter SEQ ID NO: 113 fused to 3-glucuronidase (GUS) in tobacco. Dark areas of GUS accumulation demonstrate where SEQ ID NO: 113 is active after topping. SEQ ID NO: 113 is not active in the shoot apical meristem (SAM) at the time of topping (0 h). However, SEQ ID NO: 113 is active in axillary meristems at the time of topping (0h), 24 hours after topping (24 h), and 72 hours after topping (72 h). SEQ ID NO: 113 is not active seven days after topping (7d). h=hours.

FIGS. 4A and 4B show the expression pattern of the promoter SEQ ID NO: 257 fused to GUS in tobacco. Dark areas of GUS accumulation demonstrate where SEQ ID NO: 257 is active after topping. SEQ ID NO: 257 is not active in the shoot apical meristem (SAM) at the time of topping (0 h). However, SEQ ID NO: 257 is active in axillary meristems at the time of topping (0 h), 24 hours after topping (24 h), 72 hours after topping (72 h), and seven days after topping (7 d). FIGS. 4A and 4B show different, independent tobacco lines comprising the SEQ ID NO: 257::GUS construct. h=hours.

FIG. 5 shows the expression pattern of SEQ ID NO: 113::GUS and SEQ ID NO: 257::GUS constructs in tobacco seedlings. No GUS staining was detected with either construct.

FIG. 6 shows the expression pattern of SEQ ID NO: 113::GUS in the stigma, anther, and pollen grains of tobacco. No GUS staining was detected in any of these tissues.

FIG. 7 shows photographs of wild type (control) tobacco plants and T0 tobacco plants from three independent tobacco lines comprising a SEQ ID NO: 113::Barnase (SEQ ID NO: 79) construct. The tobacco lines comprising the SEQ ID NO: 113::Barnase construct exhibit reduced suckering as compared to wild type two weeks post-topping. h=hours.

FIGS. 8A and 8B show photographs of wild type (control) tobacco plants and T1 tobacco plants from one tobacco line comprising a SEQ ID NO: 257::Barnase (SEQ ID NO: 79) construct. FIG. 8A shows the plants at the time of topping. FIG. 8B shows the plants four weeks after topping. Plants comprising the SEQ ID NO: 257::Barnase construct exhibit reduced suckering as compared to the wild type plants.

DETAILED DESCRIPTION

Unless defined otherwise, all technical and scientific terms used have the same meaning as commonly understood by one of ordinary skill in the art to which this disclosure belongs. Where a term is provided in the singular, the inventors also contemplate aspects of the disclosure described by the plural of that term. Where there are discrepancies in terms and definitions used in references that are incorporated by reference, the terms used in this application shall have the definitions given herein. Other technical terms used have their ordinary meaning in the art in which they are used, as exemplified by various art-specific dictionaries, for example, “The American Heritage® Science Dictionary” (Editors of the American Heritage Dictionaries, 2011, Houghton Mifflin Harcourt, Boston and New York), the “McGraw-Hill Dictionary of Scientific and Technical Terms” (6th edition, 2002, McGraw-Hill, New York), or the “Oxford Dictionary of Biology” (6th edition, 2008, Oxford University Press, Oxford and New York).

Any references cited herein, including, e.g., all patents, published patent applications, and non-patent publications, are incorporated herein by reference in their entirety.

When a grouping of alternatives is presented, any and all combinations of the members that make up that grouping of alternatives is specifically envisioned. For example, if an item is selected from a group consisting of A, B, C, and D, the inventors specifically envision each alternative individually (e.g., A alone, B alone, etc.), as well as combinations such as A, B, and D; And C; B and C; etc. The term “and/or” when used in a list of two or more items means any one of the listed items by itself or in combination with any one or more of the other listed items. For example, the expression “A and/or B” is intended to mean either or both of A and B—i.e., A alone, B alone, or A and B in combination. The expression “A, B and/or C” is intended to mean A alone, B alone, C alone, A and B in combination, A and C in combination, B and C in combination, or A, B, and C in combination.

When a range of numbers is provided herein, the range is understood to inclusive of the edges of the range as well as any number between the defined edges of the range. For example, “between 1 and 10” includes any number between 1 and 10, as well as the number 1 and the number 10.

As used herein, the singular form “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a compound” or “at least one compound” may include a plurality of compounds, including mixtures thereof.

Any nucleic acid molecule provided herein is envisioned for use with any method provided herein. Any nucleic acid molecule provided herein is envisioned for use with any plant or seed provided herein. Any nucleic acid molecule provided herein is envisioned for use with any tobacco plant or tobacco seed provided herein.

In an aspect, this disclosure provides a nucleic acid molecule comprising a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule.

The use of the term “polynucleotide” or “nucleic acid molecule” is not intended to limit the present disclosure to polynucleotides comprising deoxyribonucleic acid (DNA). For example, ribonucleic acid (RNA) molecules are also envisioned. Those of ordinary skill in the art will recognize that polynucleotides and nucleic acid molecules can comprise ribonucleotides and combinations of ribonucleotides and deoxyribonucleotides. Such deoxyribonucleotides and ribonucleotides include both naturally occurring molecules and synthetic analogues. The polynucleotides of the present disclosure also encompass all forms of sequences including, but not limited to, single-stranded forms, double-stranded forms, hairpins, stem-and-loop structures, and the like. In an aspect, a nucleic acid molecule provided herein is a DNA molecule. In another aspect, a nucleic acid molecule provided herein is an RNA molecule. In an aspect, a nucleic acid molecule provided herein is single-stranded. In another aspect, a nucleic acid molecule provided herein is double-stranded. A nucleic acid molecule can encode a polypeptide or a non-coding RNA.

In one aspect, a nucleic acid molecule provided herein is a plasmid or vector. In one aspect, a plasmid or vector provided herein is a recombinant vector. As used herein, the term “recombinant vector” refers to a vector formed by laboratory methods of genetic recombination, such as molecular cloning. In another aspect, a plasmid provided herein is a synthetic plasmid. As used herein, a “synthetic plasmid” is an artificially created plasmid that is capable of the same functions (e.g., replication) as a natural plasmid (e.g., Ti plasmid). Without being limited, one skilled in the art can create a synthetic plasmid de novo via synthesizing a plasmid by individual nucleotides, or by splicing together nucleic acid molecules from different pre-existing plasmids.

As used herein, the terms “vector” or “plasmid” are used interchangeably and refer to a circular, double-stranded DNA molecule that is physically separate from chromosomal DNA. In one aspect, a plasmid or vector used herein is capable of replication in vivo. A “transformation vector,” as used herein, is a plasmid that is capable of transforming a plant cell. In an aspect, a plasmid provided herein is a bacterial plasmid. In another aspect, a plasmid provided herein is an Agrobacterium Ti plasmid or derived from an Agrobacterium Ti plasmid.

As commonly understood in the art, the term “promoter” refers to a DNA sequence that contains an RNA polymerase binding site, transcription start site, and/or TATA box and assists or promotes the transcription and expression of an associated transcribable polynucleotide sequence and/or gene (or transgene). A promoter can be synthetically produced, varied or derived from a known or naturally occurring promoter sequence or other promoter sequence. A promoter can also include a chimeric promoter comprising a combination of two or more heterologous sequences. A promoter of the present application can thus include variants of promoter sequences that are similar in composition, but not identical to, other promoter sequence(s) known or provided herein.

It is understood in the art that promoters can comprise one or more “elements” that play important roles in determining when, where, and for how long a promoter is active. As used herein, an “active” promoter refers to a promoter that is initiating transcription of an operably linked nucleic acid molecule at a detectable level. One of skill in the art can determine if a promoter is active or not via any one of several methods known in the art. For example, exemplary methods of determining if a promoter is active include reverse-transcriptase polymerase chain reaction (RT-PCR), quantitative RT-PCR, and RNA sequencing. These, and other suitable methods, can be used to determine if a promoter is active by detecting the accumulation of RNA transcripts of a nucleic acid molecule operably linked to the promoter. Similarly, the activity of a promoter can be operably linked to a visual marker, such as, for example, genes encoding β-glucuronidase, luciferase, or green fluorescent protein, to determine if a promoter is active. Presence of the visual marker in a tissue sample indicates that the promoter is active in that tissue.

In one aspect, a promoter element provided herein is a bud dormancy element (SEQ ID NO: 258). In another aspect, a promoter element provided herein is a sugar repressive element (SEQ ID NO: 259). In another aspect, a promoter element provided herein is an axillary bud up2 element (SEQ ID NO: 260).

In an aspect, a promoter provided herein comprises three or fewer bud dormancy elements. In another aspect, a promoter provided herein comprises two or fewer bud dormancy elements. In another aspect, a promoter provided herein comprises one or zero bud dormancy elements. In an aspect, a promoter provided herein comprises three bud dormancy elements. In an aspect, a promoter provided herein comprises two bud dormancy elements. In an aspect, a promoter provided herein comprises one bud dormancy element. In another aspect, a promoter provided herein comprises zero bud dormancy elements. In another aspect, a promoter provided herein comprises at least three bud dormancy elements. In another aspect, a promoter provided herein comprises at least five bud dormancy elements. In another aspect, a promoter provided herein comprises between zero and five bud dormancy elements. In another aspect, a promoter provided herein comprises between zero and four bud dormancy elements. In another aspect, a promoter provided herein comprises between zero and three bud dormancy elements. In another aspect, a promoter provided herein comprises between zero and two bud dormancy elements. In another aspect, a promoter provided herein comprises between one and five bud dormancy elements. In another aspect, a promoter provided herein comprises between one and four bud dormancy elements. In another aspect, a promoter provided herein comprises between one and three bud dormancy elements. In another aspect, a promoter provided herein comprises between two and five bud dormancy elements. In another aspect, a promoter provided herein comprises between one and four bud dormancy elements.

In an aspect, a promoter provided herein comprises three or fewer sugar repressive elements. In another aspect, a promoter provided herein comprises two or fewer sugar repressive elements. In another aspect, a promoter provided herein comprises one or zero sugar repressive elements. In an aspect, a promoter provided herein comprises three sugar repressive elements. In an aspect, a promoter provided herein comprises two sugar repressive elements. In an aspect, a promoter provided herein comprises one sugar repressive element. In another aspect, a promoter provided herein comprises zero sugar repressive elements. In another aspect, a promoter provided herein comprises at least three sugar repressive elements. In another aspect, a promoter provided herein comprises at least five sugar repressive elements. In another aspect, a promoter provided herein comprises between zero and five sugar repressive elements. In another aspect, a promoter provided herein comprises between zero and four sugar repressive elements. In another aspect, a promoter provided herein comprises between zero and three sugar repressive elements. In another aspect, a promoter provided herein comprises between zero and two sugar repressive elements. In another aspect, a promoter provided herein comprises between one and five sugar repressive elements. In another aspect, a promoter provided herein comprises between one and four sugar repressive elements. In another aspect, a promoter provided herein comprises between one and three sugar repressive elements. In another aspect, a promoter provided herein comprises between two and five sugar repressive elements. In another aspect, a promoter provided herein comprises between one and four sugar repressive elements.

In another aspect, a promoter provided herein comprises one or zero axillary bud up2 elements. In another aspect, a promoter provided herein comprises one axillary bud up2 element. In another aspect, a promoter provided herein comprises zero axillary bud up2 elements. In another aspect, a promoter provided herein comprises at least one axillary bud up2 element. In another aspect, a promoter provided herein comprises at least two axillary bud up2 elements. In another aspect, a promoter provided herein comprises at least five axillary bud up2 elements. In another aspect, a promoter provided herein comprises between one and five axillary bud up2 elements. In another aspect, a promoter provided herein comprises between one and four axillary bud up2 elements. In another aspect, a promoter provided herein comprises between one and three axillary bud up2 elements.

As used herein, “operably linked” refers to a functional linkage between two or more elements. For example, an operable linkage between a polynucleotide of interest and a regulatory sequence (e.g., a promoter) is a functional link that allows for expression of the polynucleotide of interest. Operably linked elements may be contiguous or non-contiguous. In an aspect, a promoter provided herein is operably linked to a heterologous nucleic acid molecule. In another aspect, a promoter provided herein is operably linked to a heterologous nucleic acid molecule encoding at least one axillary bud-degrading product.

As used herein, the term “heterologous” refers to a combination of two or more DNA molecules or sequences, such as a promoter and an associated transcribable DNA sequence, coding sequence or gene, when such a combination is man-made and not normally found in nature.

The terms “percent identity” or “percent identical” as used herein in reference to two or more nucleotide or protein sequences is calculated by (i) comparing two optimally aligned sequences (nucleotide or protein) over a window of comparison (the “alignable” region or regions), (ii) determining the number of positions at which the identical nucleic acid base (for nucleotide sequences) or amino acid residue (for proteins) occurs in both sequences to yield the number of matched positions, (iii) dividing the number of matched positions by the total number of positions in the window of comparison, and then (iv) multiplying this quotient by 100% to yield the percent identity. If the “percent identity” is being calculated in relation to a reference sequence without a particular comparison window being specified, then the percent identity is determined by dividing the number of matched positions over the region of alignment by the total length of the reference sequence. Accordingly, for purposes of the present application, when two sequences (query and subject) are optimally aligned (with allowance for gaps in their alignment), the “percent identity” for the query sequence is equal to the number of identical positions between the two sequences divided by the total number of positions in the query sequence over its length (or a comparison window), which is then multiplied by 100%. When percentage of sequence identity is used in reference to proteins it is recognized that residue positions which are not identical often differ by conservative amino acid substitutions, where amino acid residues are substituted for other amino acid residues with similar chemical properties (e.g., charge or hydrophobicity) and therefore do not change the functional properties of the molecule. When sequences differ in conservative substitutions, the percent sequence identity can be adjusted upwards to correct for the conservative nature of the substitution. Sequences that differ by such conservative substitutions are said to have “sequence similarity” or “similarity.”

For optimal alignment of sequences to calculate their percent identity, various pair-wise or multiple sequence alignment algorithms and programs are known in the art, such as ClustalW or Basic Local Alignment Search Tool® (BLAST™), etc., that can be used to compare the sequence identity or similarity between two or more nucleotide or protein sequences. Although other alignment and comparison methods are known in the art, the alignment and percent identity between two sequences (including the percent identity ranges described above) can be as determined by the ClustalW algorithm, see, e.g., Chenna et al., “Multiple sequence alignment with the Clustal series of programs,” Nucleic Acids Research 31: 3497-3500 (2003); Thompson et al., “Clustal W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice,” Nucleic Acids Research 22: 4673-4680 (1994); Larkin M A et al., “Clustal W and Clustal X version 2.0,” Bioinformatics 23: 2947-48 (2007); and Altschul et al. “Basic local alignment search tool.” J. Mol. Biol. 215:403-410 (1990), the entire contents and disclosures of which are incorporated herein by reference.

When two sequences are optimally aligned, the alignment may produce a gap, where one sequence appears to be “missing” nucleotides as compared to the other sequences. Such a gap is referred to as a “deletion.” A deletion can be internal (e.g., the two sequences align to each other on both sides of the deletion) or external (e.g., the two sequences align to each other on only one side of the deletion).

In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 85% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 90% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 91% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 92% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 93% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 94% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 95% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 96% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 97% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 98% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 99% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises a nucleic acid sequence at least 99.5% identical to SEQ ID NO: 257. In an aspect, a promoter provided herein comprises SEQ ID NO: 257. In another aspect, a promoter provided herein consists essentially of SEQ ID NO: 257. In another aspect, a promoter provided herein consists of SEQ ID NO: 257.

In an aspect, a promoter provided herein comprises a deletion of at least 1 nucleotide as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 5 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 10 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 25 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 75 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 100 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 150 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 200 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 250 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 300 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 350 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 400 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 450 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 500 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 600 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 700 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 800 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 900 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 1000 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 1250 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 1500 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 1750 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 2000 contiguous nucleotides as compared to SEQ ID NO: 113. In another aspect, a promoter provided herein comprises a deletion of at least 2250 contiguous nucleotides as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element. In another aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element as compared to SEQ ID NO: 113. In an aspect, a promoter provided herein comprises a deletion of at least two sugar repressive elements. In another aspect, a promoter provided herein comprises a deletion of at least two sugar repressive elements as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least two sugar repressive elements. In another aspect, a deletion provided herein comprises the deletion of at least two sugar repressive elements as compared to SEQ ID NO: 113. In an aspect, a promoter provided herein comprises a deletion of at least three sugar repressive elements. In another aspect, a promoter provided herein comprises a deletion of at least three sugar repressive elements as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least three sugar repressive elements. In another aspect, a deletion provided herein comprises the deletion of at least three sugar repressive elements as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one bud dormancy element. In another aspect, a promoter provided herein comprises a deletion of at least one bud dormancy element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one bud dormancy element. In another aspect, a deletion provided herein comprises the deletion of at least one bud dormancy element as compared to SEQ ID NO: 113. In an aspect, a promoter provided herein comprises a deletion of at least two bud dormancy elements. In another aspect, a promoter provided herein comprises a deletion of at least two bud dormancy elements as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least two bud dormancy elements. In another aspect, a deletion provided herein comprises the deletion of at least two bud dormancy elements as compared to SEQ ID NO: 113. In an aspect, a promoter provided herein comprises a deletion of at least three bud dormancy elements. In another aspect, a promoter provided herein comprises a deletion of at least three bud dormancy elements as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least three bud dormancy elements. In another aspect, a deletion provided herein comprises the deletion of at least three bud dormancy elements as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one axillary bud up2 element. In another aspect, a promoter provided herein comprises a deletion of at least one axillary bud up2 element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one axillary bud up2 element. In another aspect, a deletion provided herein comprises the deletion of at least one axillary bud up2 element as compared to SEQ ID NO: 113. In an aspect, a promoter provided herein comprises a deletion of at least two axillary bud up2 elements. In another aspect, a promoter provided herein comprises a deletion of at least two axillary bud up2 elements as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least two axillary bud up2 elements. In another aspect, a deletion provided herein comprises the deletion of at least two axillary bud up2 elements as compared to SEQ ID NO: 113. In an aspect, a promoter provided herein comprises a deletion of at least three axillary bud up2 elements. In another aspect, a promoter provided herein comprises a deletion of at least three axillary bud up2 elements as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least three axillary bud up2 elements. In another aspect, a deletion provided herein comprises the deletion of at least three axillary bud up2 elements as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element and at least one axillary bud up2 element. In another aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element and at least one axillary bud up2 element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element and at least one axillary bud up2 element. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element and at least one axillary bud up2 element as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element and at least one bud dormancy element. In another aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element and at least one bud dormancy element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element and at least one bud dormancy element. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element and at least one bud dormancy element as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one axillary bud up2 element and at least one bud dormancy element. In another aspect, a promoter provided herein comprises a deletion of at least one axillary bud up2 element and at least one bud dormancy element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one axillary bud up2 element and at least one bud dormancy element. In another aspect, a deletion provided herein comprises the deletion of at least one axillary bud up 2 element and at least one bud dormancy element as compared to SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element, at least one axillary bud up2 element, and at least one bud dormancy element. In another aspect, a promoter provided herein comprises a deletion of at least one sugar repressive element, at least one axillary bud up2 element, and at least one bud dormancy element as compared to SEQ ID NO: 113. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element, at least one axillary bud up2 element, and at least one bud dormancy element. In another aspect, a deletion provided herein comprises the deletion of at least one sugar repressive element, at least one axillary bud up2 element, and at least one bud dormancy element as compared to SEQ ID NO: 113.

In an aspect, a deletion provided herein comprises the deletion of: (a) at least one sugar repressive element; (b) an axillary bud up2 element; (c) at least one bud dormancy element; or (d) any combination of (a), (b), and (c).

The terms “percent complementarity” or “percent complementary” as used herein in reference to two nucleotide sequences is similar to the concept of percent identity but refers to the percentage of nucleotides of a query sequence that optimally base-pair or hybridize to nucleotides a subject sequence when the query and subject sequences are linearly arranged and optimally base paired without secondary folding structures, such as loops, stems or hairpins. Such a percent complementarity can be between two DNA strands, two RNA strands, or a DNA strand and a RNA strand. The “percent complementarity” can be calculated by (i) optimally base-pairing or hybridizing the two nucleotide sequences in a linear and fully extended arrangement (i.e., without folding or secondary structures) over a window of comparison, (ii) determining the number of positions that base-pair between the two sequences over the window of comparison to yield the number of complementary positions, (iii) dividing the number of complementary positions by the total number of positions in the window of comparison, and (iv) multiplying this quotient by 100% to yield the percent complementarity of the two sequences. Optimal base pairing of two sequences can be determined based on the known pairings of nucleotide bases, such as G-C, A-T, and A-U, through hydrogen binding. If the “percent complementarity” is being calculated in relation to a reference sequence without specifying a particular comparison window, then the percent identity is determined by dividing the number of complementary positions between the two linear sequences by the total length of the reference sequence. Thus, for purposes of the present application, when two sequences (query and subject) are optimally base-paired (with allowance for mismatches or non-base-paired nucleotides), the “percent complementarity” for the query sequence is equal to the number of base-paired positions between the two sequences divided by the total number of positions in the query sequence over its length, which is then multiplied by 100%.

In one aspect, a promoter provided herein comprises a sequence having at least 75% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113. In one aspect, a promoter provided herein comprises a sequence having at least 80% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113. In one aspect, a promoter provided herein comprises a sequence having at least 85% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113. In one aspect, a promoter provided herein comprises a sequence having at least 90% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113. In one aspect, a promoter provided herein comprises a sequence having at least 95% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113. In one aspect, a promoter provided herein comprises a sequence having 100% identity to SEQ ID NO: 113, wherein said identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113.

In an aspect, a promoter provided herein comprises between 50 nucleotides and 2450 nucleotides. In another aspect, a promoter provided herein comprises between 100 nucleotides and 2450 nucleotides. In another aspect, a promoter provided herein comprises between 250 nucleotides and 2450 nucleotides. In another aspect, a promoter provided herein comprises between 500 nucleotides and 2450 nucleotides. In another aspect, a promoter provided herein comprises between 1000 nucleotides and 2450 nucleotides. In another aspect, a promoter provided herein comprises between 2000 nucleotides and 2450 nucleotides.

In an aspect, a promoter provided herein comprises at least 50 nucleotides. In another aspect, a promoter provided herein comprises at least 75 nucleotides. In another aspect, a promoter provided herein comprises at least 100 nucleotides. In another aspect, a promoter provided herein comprises at least 200 nucleotides. In another aspect, a promoter provided herein comprises at least 300 nucleotides. In another aspect, a promoter provided herein comprises at least 400 nucleotides. In another aspect, a promoter provided herein comprises at least 500 nucleotides. In another aspect, a promoter provided herein comprises at least 600 nucleotides. In another aspect, a promoter provided herein comprises at least 700 nucleotides. In another aspect, a promoter provided herein comprises at least 800 nucleotides. In another aspect, a promoter provided herein comprises at least 900 nucleotides. In another aspect, a promoter provided herein comprises at least 1000 nucleotides. In another aspect, a promoter provided herein comprises at least 1100 nucleotides. In another aspect, a promoter provided herein comprises at least 1200 nucleotides. In another aspect, a promoter provided herein comprises at least 1300 nucleotides. In another aspect, a promoter provided herein comprises at least 1400 nucleotides. In another aspect, a promoter provided herein comprises at least 1500 nucleotides. In another aspect, a promoter provided herein comprises at least 1600 nucleotides. In another aspect, a promoter provided herein comprises at least 1700 nucleotides. In another aspect, a promoter provided herein comprises at least 1800 nucleotides. In another aspect, a promoter provided herein comprises at least 1900 nucleotides. In another aspect, a promoter provided herein comprises at least 2000 nucleotides. In another aspect, a promoter provided herein comprises at least 2100 nucleotides. In another aspect, a promoter provided herein comprises at least 2200 nucleotides. In another aspect, a promoter provided herein comprises at least 2300 nucleotides. In another aspect, a promoter provided herein comprises at least 2400 nucleotides.

As used herein, an “axillary bud-degrading product” refers to any nucleic acid or protein that can function to inhibit the growth and/or development of an axillary bud. In one aspect, this disclosure provides a nucleic acid molecule that encodes at least one axillary bud-degrading product. In an aspect, an axillary bud-degrading product inhibits the grown of an axillary bud. In another aspect, an axillary bud-degrading product inhibits the development of an axillary bud. Without being limiting, inhibiting the development of an axillary bud can comprise slowing the progression of normal development or stopping an axillary bud from continuing normal development. In an aspect, an axillary bud-degrading product comprises an RNA. In another aspect, an axillary bud-degrading product comprises a polypeptide. In another aspect, an axillary bud-degrading product comprises a small RNA molecule. In an aspect, an axillary bud-degrading product is selected from the group consisting of a small RNA molecule and a polypeptide. In an aspect, a nucleic acid molecule provided herein encodes an axillary bud-degrading product. In another aspect, a heterologous nucleic acid provided herein encodes at least one axillary bud-degrading product.

As used herein, the term “polypeptide” refers to a chain of at least two covalently linked amino acids. Polypeptides can be encoded by polynucleotides provided herein. An example of a polypeptide is a protein. Proteins provided herein can be encoded by nucleic acid molecules provided herein.

In an aspect, a polypeptide provided herein comprises an amino acid sequence at least 70% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 75% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 80% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 85% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 90% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 95% identical to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255.

In an aspect, a polypeptide provided herein comprises an amino acid sequence at least 70% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 75% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 80% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 85% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 90% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence at least 95% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. In another aspect, a polypeptide provided herein comprises an amino acid sequence 100% similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255.

As used herein, a “small RNA molecule” refers to any non-coding RNA molecule. In an aspect, a small RNA molecule is between 18 nucleotides and 30 nucleotides in length. In another aspect, a small RNA molecule is between 18 nucleotides and 24 nucleotides in length. In another aspect, a small RNA molecule is between 18 nucleotides and 22 nucleotides in length. In another aspect, a small RNA molecule is 18 nucleotides in length. In another aspect, a small RNA molecule is 19 nucleotides in length. In another aspect, a small RNA molecule is 20 nucleotides in length. In another aspect, a small RNA molecule is 21 nucleotides in length. In another aspect, a small RNA molecule is 22 nucleotides in length. In another aspect, a small RNA molecule is 23 nucleotides in length. In another aspect, a small RNA molecule is 24 nucleotides in length. In another aspect, a small RNA molecule is 25 nucleotides in length. In another aspect, a small RNA molecule is 26 nucleotides in length. In another aspect, a small RNA molecule is 27 nucleotides in length. In another aspect, a small RNA molecule is 28 nucleotides in length. In another aspect, a small RNA molecule is at least 18 nucleotides in length. In another aspect, a small RNA molecule is at least 19 nucleotides in length. In another aspect, a small RNA molecule is at least 20 nucleotides in length. In another aspect, a small RNA molecule is at least 21 nucleotides in length. In another aspect, a small RNA molecule is at least 22 nucleotides in length. In another aspect, a small RNA molecule is at least 23 nucleotides in length. In another aspect, a small RNA molecule is at least 24 nucleotides in length. In another aspect, a small RNA molecule is at least 25 nucleotides in length. In another aspect, a small RNA molecule is at least 26 nucleotides in length. In another aspect, a small RNA molecule is at least 27 nucleotides in length. In another aspect, a small RNA molecule is at least 28 nucleotides in length.

In an aspect, a small RNA molecule provided herein is a microRNA (miRNA). In another aspect, a small RNA molecule provided herein is a small interfering RNA (siRNA). In another aspect, a small RNA molecule provided herein is a heterochromatic siRNA (hc-siRNA). In another aspect, a small RNA molecule provided herein is a Piwi-interacting RNA (piRNA). In another aspect, a small RNA molecule provided herein is a hairpin double-stranded RNA (hp-dsRNA). In another aspect, a small RNA molecule provided herein is a trans-acting siRNA (ta-siRNA). In another aspect, a small RNA molecule provided herein is a naturally occurring antisense siRNA (nat-siRNA). In another aspect, a small RNA molecule provided herein is a Cas9-guide RNA (gRNA). In another aspect, a small RNA molecule provided herein is a Cpf1-gRNA. In another aspect, a small RNA molecule provided herein is a CasX-gRNA. In another aspect, a small RNA molecule provided herein is a Csm1-gRNA.

In an aspect, a small RNA molecule provided herein comprises at least 18 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 19 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 20 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 21 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 22 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 23 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 24 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 25 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 26 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 27 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101. In another aspect, a small RNA molecule provided herein comprises at least 28 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101.

In one aspect, this disclosure provides a tobacco plant comprising a nucleic acid molecule comprising a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between the sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule, where the tobacco plant comprises no suckers or reduced suckers after topping as compared to a control tobacco plant of the same variety when grown under comparable conditions.

In another aspect, this disclosure provides a plant comprising a nucleic acid molecule comprising a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between the sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule, where the plant comprises no suckers or reduced suckers after topping as compared to a control plant of the same variety when grown under comparable conditions.

In yet another aspect, this disclosure provides a plant or seed comprising a nucleic acid molecule, where the nucleic acid molecule comprises a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between the sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule encoding an axillary bud-degrading product. In an aspect, a plant provided herein comprises no or reduced suckers as compared to a control plant when grown under comparable conditions.

As used herein, “plant” refers to a whole plant. A cell or tissue culture derived from a plant can comprise any plant components or plant organs (e.g., leaves, stems, roots, etc.), plant tissues, seeds, plant cells, and/or progeny of the same. A progeny plant can be from any filial generation, e.g., F₁, F₂, F₃, F₄, F₅, F₆, F₇, etc. A plant cell is a biological cell of a plant, taken from a plant or derived through culture from a cell taken from a plant. As used herein, “seedling” refers to a plant that is equal to, or less than, 14 days post-germination.

In one aspect, a plant component provided herein includes, but is not limited to, a leaf, a stem, a root, a seed, a flower, pollen, an anther, an ovule, a pedicel, a fruit, a meristem, a cotyledon, a hypocotyl, a pod, an embryo, endosperm, an explant, a callus, a tissue culture, a shoot, a cell, and a protoplast. In further aspects, this disclosure provides plant cells, tissues, and organs that are not reproductive material and do not mediate the natural reproduction of the plant. In another aspect, this disclosure also provides plant cells, tissues, and organs that are reproductive material and mediate the natural reproduction of the plant. In another aspect, this disclosure provides plant cells, tissues, and organs that cannot maintain themselves via photosynthesis. In another aspect, this disclosure provides somatic plant cells. Somatic cells, contrary to germline cells, do not mediate plant reproduction.

Provided cells, tissues and organs can be from seed, fruit, leaf, cotyledon, hypocotyl, meristem, embryos, endosperm, root, shoot, stem, pod, flower, inflorescence, stalk, pedicel, style, stigma, receptacle, petal, sepal, pollen, anther, filament, ovary, ovule, pericarp, phloem, and vascular tissue. In another aspect, this disclosure provides a plant chloroplast. In a further aspect, this disclosure provides an epidermal cell, a stomata cell, a trichome cell, a root hair, or a storage root.

In an aspect, this disclosure provides a tobacco protoplast cell. In another aspect, this disclosure provides a tobacco callus cell. In another aspect, this disclosure provides a tobacco seed cell. In another aspect, this disclosure provides a tobacco seed cell. In another aspect, this disclosure provides a tobacco fruit cell. In another aspect, this disclosure provides a tobacco leaf cell. In another aspect, this disclosure provides a tobacco cotyledon cell. In another aspect, this disclosure provides a tobacco hypocotyl cell. In another aspect, this disclosure provides a tobacco meristem cell. In another aspect, this disclosure provides a tobacco embryo cell. In another aspect, this disclosure provides a tobacco root cell. In another aspect, this disclosure provides a tobacco shoot cell. In another aspect, this disclosure provides a tobacco stem cell. In another aspect, this disclosure provides a tobacco flower cell. In another aspect, this disclosure provides a tobacco inflorescence cell. In another aspect, this disclosure provides a tobacco stalk cell. In another aspect, this disclosure provides a tobacco pedicel cell. In another aspect, this disclosure provides a tobacco style cell. In another aspect, this disclosure provides a tobacco stigma cell. In another aspect, this disclosure provides a tobacco receptacle cell. In another aspect, this disclosure provides a tobacco petal cell. In another aspect, this disclosure provides a tobacco sepal cell. In another aspect, this disclosure provides a tobacco pollen cell. In another aspect, this disclosure provides a tobacco anther cell. In another aspect, this disclosure provides a tobacco filament cell. In another aspect, this disclosure provides a tobacco ovary cell. In another aspect, this disclosure provides a tobacco ovule cell. In another aspect, this disclosure provides a tobacco pericarp cell. In another aspect, this disclosure provides a tobacco phloem cell.

Tobacco is known in the art as a plant from the family Solanaceae. Non-limiting exemplary tobacco species include Nicotiana acuminata, Nicotiana africana, Nicotiana alata, Nicotiana attenuata, Nicotiana benthamiana, Nicotiana clevelandii, Nicotiana exigua, Nicotiana glauca, Nicotiana glutinosa, Nicotiana langsdorffii, Nicotiana longiflora, Nicotiana occidentalis, Nicotiana obtusifolia, Nicotiana otophora, Nicotiana plumbaginifolia, Nicotiana quadrivalvis, Nicotiana rustica, Nicotiana suaveolens, Nicotiana sylvestris, Nicotiana tabacum, and Nicotiana tomentosiformis. In one aspect, tobacco refers to Nicotiana tabacum.

In an aspect, a plant provided herein is a tobacco plant. In another aspect, a seed provided herein is a tobacco seed. In another aspect, a leaf provided herein is a tobacco leaf. In another aspect, a plant cell provided herein is a tobacco cell. In another aspect, a plant tissue provided herein is a tobacco tissue. In another aspect, a plant organ provided herein is a tobacco organ. In a further aspect, a plant component provided herein is a tobacco component.

In an aspect, a plant provided herein is a modified plant. In another aspect, a seed provided herein is a modified seed. In a further aspect, a plant component provided herein is a modified plant component. In an aspect, a plant cell provided herein is a modified plant cell. In another aspect, a plant genome provided herein is a modified plant genome. As used herein, “modified” refers to plants, seeds, plant components, plant cells, and plant genomes that have been subjected to mutagenesis, genome editing, genetic transformation, or a combination thereof. In an aspect, this disclosure provides a tobacco plant. In another aspect, this disclosure provides a tobacco seed. In a further aspect, this disclosure provides a tobacco leaf. In still a further aspect, this disclosure provides a modified cured tobacco leaf.

In an aspect, this disclosure provides a tobacco plant comprising any nucleic acid molecule provided herein. In another aspect, this disclosure provides a tobacco seed comprising any nucleic acid molecule provided herein. In a further aspect, this disclosure provides a tobacco leaf comprising any nucleic acid molecule provided herein. In still a further aspect, this disclosure provides a cured tobacco leaf comprising any nucleic acid molecule provided herein. In an aspect, this disclosure provides a plant comprising any nucleic acid molecule provided herein. In another aspect, this disclosure provides a seed comprising any nucleic acid molecule provided herein. In a further aspect, this disclosure provides a leaf comprising any nucleic acid molecule provided herein.

As used herein, “suckering” refers to the development and/or growth of axillary (or lateral) buds (“suckers”) from axillary meristems that grow between a leaf and the stalk. An axillary bud is an embryonic shoot that comprises an axillary meristem, surrounding leaf tissue, and surrounding stem tissue. In one aspect, suckering is induced by topping a plant.

Dicot shoot apical and axillary meristems comprise three distinct cell layers: the L1 layer (outermost layer), the L2 layer (middle layer), and the L3 layer (innermost layer). The L1 and L2 layers make up the tunica, and they divide anticlinally (the division plane is perpendicular to the surface of the meristem). The L3 layer, or corpus, divides in all directions. The L1 layer eventually gives rise to epidermal tissue; the L2 layer gives rise to ground tissue (e.g., parenchyma, collenchyma, sclerenchyma); and the L3 layer typically gives rise to vascular tissue (e.g., xylem, phloem).

Shoot apical and axillary meristems have two main functions: to maintain themselves as a group of pluripotent cells, and to generate lateral above-ground organs of the plant (e.g., stems, leaves, flowers). If a meristem fails to maintain itself, for any reason, it will eventually exhaust its pluripotent cells and cease giving rise to additional organs. In one aspect, a tobacco plant provided herein exhibits inhibited or eliminated axillary meristem growth; inhibited or eliminated axillary meristem maintenance; or a combination thereof compared to a control tobacco plant of the same variety when grown under comparable conditions.

In one aspect, a promoter provided herein is active in axillary meristem tissue. In another aspect, a promoter provided herein is active in axillary bud tissue. In an aspect, a promoter provided herein is active in axillary meristem tissue at least 7 days after topping. In another aspect, a promoter provided herein is active in axillary bud tissue at least 7 days after topping. In an aspect, a promoter provided herein is not active in a seedling tobacco plant. In another aspect, a promoter provided herein is not active in a seedling plant. In another aspect, a promoter provided herein is not active in a tobacco seed. In another aspect, a promoter provided herein is not active in a seed. In a further aspect, a promoter provided herein is not active in a tobacco embryo. In another aspect, a promoter provided herein is not active in a plant embryo. In an aspect, a promoter provided herein is not active in a tobacco pollen cell. In another aspect, a promoter provided herein is not active in a pollen cell. In an aspect, a promoter provided herein is not active in a tobacco egg cell. In another aspect, a promoter provided herein is not active in a plant egg cell. In an aspect, a promoter provided herein is not active in shoot apical meristem tissue.

As used herein, “topping” refers to the removal of the stalk apex, including the SAM, flowers, and up to several adjacent leaves, when a plant is near maturity. Topping a tobacco plant results in the loss of apical dominance. Prior to topping, suckering is largely kept dormant by hormonal signals emanating from the SAM; topping removes the hormonal signals and can allow the outgrowth of suckers (“topping-induced suckering”). Provided suckering is sufficiently controlled, topping increases yield, increases value-per-acre, and results in desirable modifications to physical and chemical properties of tobacco leaves.

As used herein, “comparable growth conditions” refers to similar environmental conditions and/or agronomic practices for growing and making meaningful comparisons between two or more plant genotypes so that neither environmental conditions nor agronomic practices would contribute to, or explain, any differences observed between the two or more plant genotypes. Environmental conditions include, for example, light, temperature, water, humidity, and nutrition (e.g., nitrogen and phosphorus). Agronomic practices include, for example, seeding, clipping, undercutting, transplanting, topping, and suckering. See Chapters 4B and 4C of Tobacco, Production, Chemistry and Technology, Davis & Nielsen, eds., Blackwell Publishing, Oxford (1999), pp. 70-103.

As used herein, “reduced topping-induced suckering” or “reduced suckering” refers to a reduction in the number of suckers; a reduction in the size of suckers (e.g., dry biomass, fresh weight, length, diameter), and/or a reduction of the impact suckers have on agronomic performance (e.g., yield, quality and overall productivity of the plant) compared to a control plant when grown under comparable conditions after topping. As used herein, a “reduction” in the number of suckers, the size of suckers, and/or the impact suckers have on agronomic performance refers to a statistically significant reduction. As used herein, “statistically significant” refers to a p-value of less than 0.05 when using an appropriate measure of statistical significance (e.g., a one-tailed two sample t-test).

Unless specified otherwise, measurements of sucker length, sucker biomass, number of suckers, leaf yield, or leaf grade index values mentioned herein for a tobacco plant, variety, cultivar, or line refer to average measurements, including, for example, an average of multiple leaves (e.g., 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, or 20 or more leaves) of a single plant or an average measurement from a population of tobacco plants from a single variety, cultivar, or line. A population of tobacco plants or a collection of tobacco leaves for determining an average measurement (e.g., fresh weight, dry biomass, or leaf grading) can be of any size, for example, 5, 10, 15, 20, 25, 30, 35, 40, or 50. Industry-accepted standard protocols are followed for determining average measurements or grade index values.

In an aspect, reduced suckering comprises a reduction in the dry biomass of suckers. In an aspect, reduced suckering comprises a reduction in the fresh weight of suckers. In another aspect, reduced suckering comprises a reduction in the length of suckers. In still another aspect, reduced suckering comprises a reduction in the number of suckers present. In an aspect, reduced suckering comprises a reduction in the dry biomass of suckers, the reduction in the fresh weight of suckers, a reduction in the length of suckers, a reduction in the diameter of suckers, reduced number of total suckers, or any combination thereof.

In an aspect, the number of suckers is counted one week after topping. In another aspect, the number of suckers is counted two weeks after topping. In another aspect, the number of suckers is counted three weeks after topping. In another aspect, the number of suckers is counted four weeks after topping. In another aspect, the number of suckers is counted five weeks after topping. In another aspect, the number of suckers is counted six weeks after topping. In another aspect, the number of suckers is counted seven weeks after topping. In another aspect, the number of suckers is counted eight weeks after topping. In another aspect, the number of suckers is counted nine weeks after topping. In another aspect, the number of suckers is counted ten weeks after topping.

In an aspect, the fresh weight of suckers is measured one week after topping. In another aspect, the fresh weight of suckers is measured two weeks after topping. In another aspect, the fresh weight of suckers is measured three weeks after topping. In another aspect, the fresh weight of suckers is measured four weeks after topping. In another aspect, the fresh weight of suckers is measured five weeks after topping. In another aspect, the fresh weight of suckers is measured six weeks after topping. In another aspect, the fresh weight of suckers is measured seven weeks after topping. In another aspect, the fresh weight of suckers is measured eight weeks after topping. In another aspect, the fresh weight of suckers is measured nine weeks after topping. In another aspect, the fresh weight of suckers is measured ten weeks after topping.

In an aspect, the dry biomass of suckers is measured one week after topping. In another aspect, the dry biomass of suckers is measured two weeks after topping. In another aspect, the dry biomass of suckers is measured three weeks after topping. In another aspect, the dry biomass of suckers is measured four weeks after topping. In another aspect, the dry biomass of suckers is measured five weeks after topping. In another aspect, the dry biomass of suckers is measured six weeks after topping. In another aspect, the dry biomass of suckers is measured seven weeks after topping. In another aspect, the dry biomass of suckers is measured eight weeks after topping. In another aspect, the dry biomass of suckers is measured nine weeks after topping. In another aspect, the dry biomass of suckers is measured ten weeks after topping.

The length of a sucker is measured as the distance between the sucker base (where it attaches to the main stem of the plant) and the part of the sucker most distant from the sucker base. In an aspect, the length of suckers is measured one week after topping. In another aspect, the length of suckers is measured two weeks after topping. In another aspect, the length of suckers is measured three weeks after topping. In another aspect, the length of suckers is measured four weeks after topping. In another aspect, the length of suckers is measured five weeks after topping. In another aspect, the length of suckers is measured six weeks after topping. In another aspect, the length of suckers is measured seven weeks after topping. In another aspect, the length of suckers is measured eight weeks after topping. In another aspect, the length of suckers is measured nine weeks after topping. In another aspect, the length of suckers is measured ten weeks after topping.

The diameter of a sucker is measured at its base, where it adjoins to the main stem of the plant. In an aspect, the diameter of suckers is measured one week after topping. In another aspect, the diameter of suckers is measured two weeks after topping. In another aspect, the diameter of suckers is measured three weeks after topping. In another aspect, the diameter of suckers is measured four weeks after topping. In another aspect, the diameter of suckers is measured five weeks after topping. In another aspect, the diameter of suckers is measured six weeks after topping. In another aspect, the diameter of suckers is measured seven weeks after topping. In another aspect, the diameter of suckers is measured eight weeks after topping. In another aspect, the diameter of suckers is measured nine weeks after topping. In another aspect, the diameter of suckers is measured ten weeks after topping.

In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 10% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 15% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 20% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 25% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 30% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 35% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 40% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 45% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 50% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 55% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 60% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 65% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 70% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 75% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 80% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 85% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 90% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is at least 95% reduced compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 25% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 50% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 75% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 100% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 25% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 50% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 75% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 100% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 25% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 50% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 75% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 100% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 25% and 50% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 25% and 75% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 25% and 100% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 50% and 75% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 50% and 100% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the fresh weight biomass of suckers of a tobacco plant provided herein is reduced by between 75% and 100% as compared to the fresh weight biomass of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 10% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 15% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 20% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 25% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 30% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 35% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 40% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 45% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 50% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 55% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 60% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 65% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 70% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 75% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 80% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 85% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 90% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the dry weight biomass of suckers of a tobacco plant provided herein is at least 95% reduced compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 25% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 50% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 75% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 1% and 100% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 25% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 50% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 75% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 5% and 100% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 25% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 50% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 75% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 10% and 100% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 25% and 50% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 25% and 75% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 25% and 100% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 50% and 75% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 50% and 100% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the dry weight biomass of suckers of a tobacco plant provided herein is reduced by between 75% and 100% as compared to the dry weight biomass of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the length of suckers of a tobacco plant provided herein is at least 10% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 15% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 20% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 25% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 30% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 35% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 40% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 45% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 50% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 55% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 60% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 65% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 70% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 75% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 80% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 85% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 90% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the length of suckers of a tobacco plant provided herein is at least 95% reduced compared to the length of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 1% and 25% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 1% and 50% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 1% and 75% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 1% and 100% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 5% and 25% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 5% and 50% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 5% and 75% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 5% and 100% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 10% and 25% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 10% and 50% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 10% and 75% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 10% and 100% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 25% and 50% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 25% and 75% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 25% and 100% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 50% and 75% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 50% and 100% as compared to the length of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the length of suckers of a tobacco plant provided herein is reduced by between 75% and 100% as compared to the length of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the diameter of suckers of a tobacco plant provided herein is at least 10% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 15% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 20% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 25% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 30% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 35% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 40% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 45% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 50% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 55% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 60% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 65% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 70% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 75% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 80% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 85% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 90% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In another aspect, the diameter of suckers of a tobacco plant provided herein is at least 95% reduced compared to the diameter of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 1% and 25% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 1% and 50% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 1% and 75% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 1% and 100% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 5% and 25% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 5% and 50% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 5% and 75% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 5% and 100% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 10% and 25% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 10% and 50% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 10% and 75% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 10% and 100% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 25% and 50% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 25% and 75% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 25% and 100% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 50% and 75% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 50% and 100% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions. In an aspect, the diameter of suckers of a tobacco plant provided herein is reduced by between 75% and 100% as compared to the diameter of suckers of a control tobacco plant grown under comparable conditions.

In an aspect, a tobacco plant provided herein comprises at least 1 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 2 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 3 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 4 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 5 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 6 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 7 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 8 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 9 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 10 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 15 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 20 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 30 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 40 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 50 fewer total suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 60 fewer total suckers compared to a control tobacco plant grown under comparable conditions.

In an aspect, a tobacco plant provided herein comprises at least 10% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 15% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 20% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 25% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 30% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 35% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 40% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 45% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 50% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 55% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 60% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 65% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 70% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 75% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 80% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 85% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 90% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises at least 95% fewer suckers compared to a control tobacco plant grown under comparable conditions.

In an aspect, a tobacco plant provided herein comprises between 1% and 25% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 1% and 50% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 1% and 75% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 1% and 100% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 5% and 25% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 5% and 50% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 5% and 75% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 5% and 100% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 10% and 25% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 10% and 50% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 10% and 75% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 10% and 100% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 25% and 50% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 25% and 75% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 25% and 100% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 50% and 75% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 50% and 100% fewer suckers compared to a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises between 75% and 100% fewer suckers compared to a control tobacco plant grown under comparable conditions.

In one aspect, a tobacco plant provided herein comprises a similar or higher leaf yield mass compared to a control tobacco plant when grown under comparable conditions. As used herein, “similar” refers to within 10%. In an aspect, leaf yield mass is selected from the group consisting of fresh yield mass, dry yield mass, and cured yield mass. In another aspect, a tobacco plant provided herein comprises a higher leaf yield mass as compared to a control tobacco plant. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 50% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 45% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 40% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 35% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 30% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 25% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 20% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 15% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 10% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 5% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 4% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 3% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 2% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 1% of the leaf yield mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a leaf yield mass within 0.5% of the leaf yield mass of a control tobacco plant when grown under comparable conditions.

In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 0.25% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 0.5% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 1% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 2.5% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 5% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 10% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 15% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 20% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 25% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 30% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 40% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 50% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 60% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 70% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 80% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 90% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 100% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass at least 150% more than the dry leaf mass of a control tobacco plant when grown under comparable conditions.

In an aspect, a tobacco plant provided herein produces a dry leaf mass between 0.25% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 0.5% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 1% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 2.5% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 5% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 10% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 15% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 20% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 25% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 30% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 40% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 50% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 60% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 70% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 80% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 90% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a dry leaf mass between 100% and 150% of the dry leaf mass of a control tobacco plant when grown under comparable conditions.

In an aspect, a tobacco plant provided herein produces a number of leaves within 75% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 60% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 50% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 25% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 15% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 10% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 5% of the number of leaves produced by a control tobacco plant grown under comparable conditions. In an aspect, a tobacco plant provided herein produces a number of leaves within 1% of the number of leaves produced by a control tobacco plant grown under comparable conditions.

In one aspect, a tobacco plant provided herein comprises a similar plant height compared to a control tobacco plant when grown under comparable conditions. In an aspect, plant height is measured as the distance between the uppermost surface of the growth media (e.g., soil) in which the plant is growing and the uppermost surface of the uppermost leaf of the plant. In an aspect, a tobacco plant comprises a height that is equal to or greater than the height of a control plant. In an aspect, a tobacco plant provided herein comprises a height at least 75% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 50% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 25% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 20% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 15% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 10% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 5% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 2.5% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 1% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 0.75% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 0.5% greater than the height of a control tobacco plant when grown under comparable conditions. In an aspect, a tobacco plant provided herein comprises a height at least 0.25% greater than the height of a control tobacco plant when grown under comparable conditions.

Tobacco grades are evaluated based on factors including, but not limited to, the leaf stalk position, leaf size, leaf color, leaf uniformity and integrity, ripeness, texture, elasticity, sheen (related with the intensity and the depth of coloration of the leaf as well as the shine), hygroscopicity (the faculty of the tobacco leaves to absorb and to retain the ambient moisture), and green nuance or cast. Leaf grade can be determined, for example, using an Official Standard Grade published by the Agricultural Marketing Service of the US Department of Agriculture (7 U.S.C. § 511). See, e.g., Official Standard Grades for Burley Tobacco (U.S. Type 31 and Foreign Type 93), effective Nov. 5, 1990 (55 F.R. 40645); Official Standard Grades for Flue-Cured Tobacco (U.S. Types 11, 12, 13, 14 and Foreign Type 92), effective Mar. 27, 1989 (54 F.R. 7925); Official Standard Grades for Pennsylvania Seedleaf Tobacco (U.S. Type 41), effective Jan. 8, 1965 (29 F.R. 16854); Official Standard Grades for Ohio Cigar-Leaf Tobacco (U.S. Types 42, 43, and 44), effective Dec. 8, 1963 (28 F.R. 11719 and 28 F.R. 11926); Official Standard Grades for Wisconsin Cigar-Binder Tobacco (U.S. Types 54 and 55), effective Nov. 20, 1969 (34 F.R. 17061); Official Standard Grades for Wisconsin Cigar-Binder Tobacco (U.S. Types 54 and 55), effective Nov. 20, 1969 (34 F.R. 17061); Official Standard Grades for Georgia and Florida Shade-Grown Cigar-Wrapper Tobacco (U.S. Type 62), Effective April 1971. A USDA grade index value can be determined according to an industry accepted grade index. See, e.g., Bowman et al, Tobacco Science, 32:39-40(1988); Legacy Tobacco Document Library (Bates Document #523267826-523267833, Jul. 1, 1988, Memorandum on the Proposed Burley Tobacco Grade Index); and Miller et al., 1990, Tobacco Intern., 192:55-57 (all foregoing references are incorporated by inference in their entirety). Alternatively, leaf grade can be determined via hyper-spectral imaging. See e.g., WO 2011/027315 (published on Mar. 10, 2011, and incorporated by inference in its entirety).

In one aspect, a tobacco plant provided herein produces leaves that have a similar or higher USDA grade index value compared to a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 50% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 45% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 40% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 35% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 30% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 25% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 20% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 15% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 10% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 5% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 4% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 3% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 2% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 1% of the USDA grade index value of a control tobacco plant when grown under comparable conditions. In one aspect, a tobacco plant provided herein produces leaves with a USDA grade index value within about 0.5% of the USDA grade index value of a control tobacco plant when grown under comparable conditions.

In one aspect, a plant provided herein requires reduced management for controlling suckering compared to a control plant when grown under comparable conditions. As used herein, “management” refers to manually removing suckers, application of chemicals (e.g., maleic hydrazide, flumetralin) to inhibit or remove suckers, or both. In one aspect, a plant provided herein requires reduced frequency of manual sucker removal, reduced frequency of chemical application, reduced quantities of chemical application, or a combination thereof, compared to a control plant grown under comparable conditions. See, for example, Fisher et al. “Topping, Managing Suckers, and Using Ethephon,” pages 96-117 In: 2016 Flue-Cured Tobacco Information, North Carolina State University, which is herein incorporated by reference in its entirety.

In one aspect, a plant or leaf provided herein has a similar leaf chemistry profile compared to a control plant when grown under comparable conditions. Without being limiting, a leaf chemistry profile can comprise the amount of alkaloids (e.g., nicotine, nornicotine, anabasine, anatabine), malic acid, and reducing sugars (e.g., dextrose), or a combination thereof in a tobacco plant or tobacco leaf. Without being limiting, leaf chemistry can be measured as milligrams per gram of dry leaf mass or as a percent of total dry leaf mass.

In an aspect, a plant or leaf provided herein comprises a total alkaloids level within 50% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 40% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 30% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 25% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 20% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 15% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 10% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 5% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 4% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 3% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 2% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 1% of the total alkaloids level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a total alkaloids level within 0.5% of the total alkaloids level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises a nicotine level within 50% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 40% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 30% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 25% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 20% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 15% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 10% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 5% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 4% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 3% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 2% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 1% of the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nicotine level within 0.5% of the nicotine level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises a nornicotine level within 50% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 40% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 30% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 25% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 20% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 15% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 10% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 5% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 4% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 3% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 2% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 1% of the nornicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a nornicotine level within 0.5% of the nornicotine level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises an anabasine level within 50% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 40% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 30% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 25% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 20% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 15% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 10% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 5% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 4% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 3% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 2% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 1% of the anabasine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anabasine level within 0.5% of the anabasine level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises an anatabine level within 50% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 40% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 30% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 25% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 20% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 15% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 10% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 5% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 4% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 3% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 2% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 1% of the anatabine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises an anatabine level within 0.5% of the anatabine level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises a malic acid level within 50% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 40% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 30% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 25% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 20% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 15% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 10% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 5% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 4% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 3% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 2% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 1% of the malic acid level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a malic acid level within 0.5% of the total malic acid level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises a reducing sugars level within 50% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 40% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 30% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 25% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 20% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 15% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 10% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 5% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 4% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 3% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 2% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 1% of the reducing sugars level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a reducing sugars level within 0.5% of the reducing sugars level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises a dextrose level within 50% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 40% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 30% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 25% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 20% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 15% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 10% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 5% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 4% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 3% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 2% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 1% of the dextrose level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises a dextrose level within 0.5% of the dextrose level of a control plant when grown under comparable conditions.

In an aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 50% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 60% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 70% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 80% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 90% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 95% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 96% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 97% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 98% lower than the nicotine level of a control plant when grown under comparable conditions. In another aspect, a plant or leaf provided herein comprises no or reduced suckers compared to a control plant and further comprises a nicotine level at least 99% lower than the nicotine level of a control plant when grown under comparable conditions.

In one aspect, this disclosure provides tobacco leaves from any plant provided herein.

Tobacco material obtained from tobacco plants, cells, lines, varieties, or hybrids of the present disclosure can be used to make tobacco products. As used herein, “tobacco product” is defined as any product made or derived from tobacco that is intended for human use or consumption. In an aspect, a tobacco product provided herein comprises cured components from a tobacco plant provided herein. In another aspect, a tobacco product provided herein comprises cured tobacco leaves from a tobacco plant provided herein. In an aspect, this disclosure provides a tobacco product comprising cured tobacco material from any tobacco plant provided herein.

Alkaloid compounds can be extracted, or isolated, from any tobacco plant or plant part provided herein. In an aspect, a tobacco product provided herein comprises an alkaloid extracted from a tobacco plant or tobacco plant part. In another aspect, a tobacco product provided herein comprises nicotine extracted from a tobacco plant or tobacco plant part. In another aspect, a tobacco product provided herein comprises anatabine extracted from a tobacco plant or tobacco plant part. In another aspect, a tobacco product provided herein comprises anabasine extracted from a tobacco plant or tobacco plant part. In an aspect, a tobacco product provided herein comprises nornicotine extracted from a tobacco plant or plant part.

In an aspect, cured tobacco material provided herein comprises air-cured tobacco material. In another aspect, cured tobacco material provided herein comprises fire-cured tobacco material. In another aspect, cured tobacco material provided herein comprises sun-cured tobacco material. In another aspect, cured tobacco material provided herein comprises flue-cured tobacco material. In another aspect, cured tobacco material provided herein is selected from the group consisting of air-cured tobacco material, fire-cured tobacco material, sun-cured tobacco material, and flue-cured tobacco material.

Tobacco products provided herein include, without limitation, cigarette products (e.g., cigarettes, bidi cigarettes, kreteks), cigar products (e.g., cigars, cigar wrapping tobacco, cigarillos), pipe tobacco products, products derived from tobacco, tobacco-derived nicotine products, smokeless tobacco products (e.g., moist snuff, dry snuff, chewing tobacco, moist smokeless tobacco, fine cut chewing tobacco, long cut chewing tobacco, pouched chewing tobacco), films, chewables (e.g., gum), lozenges, dissolving strips, tabs, tablets, shaped parts, gels, consumable units, insoluble matrices, hollow shapes, reconstituted tobacco, expanded tobacco, and the like. See, for example, U.S. Patent Publication No. US 2006/0191548. In an aspect, a tobacco product is selected from the group consisting of a cigarette, a kretek, a bidi cigarette, a cigar, a cigarillo, a non-ventilated cigarette, a vented-recess filter cigarette, pipe tobacco, snuff, chewing tobacco, moist smokeless tobacco, fine cut chewing tobacco, long cut chewing tobacco, and pouched chewing tobacco. In another aspect, a tobacco product is selected from the group consisting of a gum, a tablet, a lozenge, and a dissolving strip. In another aspect, a tobacco product provided herein is a smokeless tobacco product.

Alkaloid compounds extracted from tobacco plants or tobacco plant parts provided herein can be used to produce compositions suitable for use with non-combustible products. Exemplary non-combustible products include electronic cigarettes (“e-cigarettes”), electronic smoking articles, e-vapor products, aerosolized vapor products, and heated tobacco products. In an aspect, a non-combustible product provided herein comprises an alkaloid extracted from a tobacco plant or tobacco plant part provided herein. In an aspect, a non-combustible product provided herein comprises nicotine extracted from a tobacco plant or tobacco plant part provided herein. In an aspect, a non-combustible product provided herein comprises anabasine extracted from a tobacco plant or tobacco plant part provided herein. In an aspect, a non-combustible product provided herein comprises anatabine extracted from a tobacco plant or tobacco plant part provided herein. In an aspect, a non-combustible product provided herein comprises nornicotine extracted from a tobacco plant or tobacco plant part provided herein.

In one aspect, a non-combustible product provided herein is an e-cigarette. In another aspect, a non-combustible product provided herein is an electronic smoking article. In another aspect, a non-combustible product provided herein is an aerosolized vapor product. In another aspect, a non-combustible product provided herein is a heated tobacco product. In another aspect, a non-combustible product provided herein is an e-vapor product. In an aspect, a non-combustible product provided herein is selected from the group consisting of an e-cigarette, an electronic smoking article, an aerosolized vapor product, and a heated tobacco product.

As used herein, “cigarette” refers a tobacco product having a “rod” and “filler”. The cigarette “rod” includes the cigarette paper, filter, plug wrap (used to contain filtration materials), tipping paper that holds the cigarette paper (including the filler) to the filter, and all glues that hold these components together. The “filler” includes (1) all tobaccos, including but not limited to reconstituted and expanded tobacco, (2) non-tobacco substitutes (including but not limited to herbs, non-tobacco plant materials and other spices that may accompany tobaccos rolled within the cigarette paper), (3) casings, (4) flavorings, and (5) all other additives (that are mixed into tobaccos and substitutes and rolled into the cigarette).

In an aspect, this disclosure provides containers of tobacco leaves used to store, transport, or otherwise house cured or uncured tobacco leaves from tobacco plants described herein. As a non-limiting example, a container can be a box, a bag, a barrel, a crate, or any other suitable container.

In another aspect, this disclosure provides a bale of cured tobacco leaves from any tobacco plant provided herein. Also provided herein is a bale of uncured tobacco leaves from any tobacco plant provided herein. A bale can be any size known in the art. In one aspect, a bale comprises at least 1 kilogram. In another aspect, a bale comprises at least 5 kilograms. In another aspect, a bale comprises at least 10 kilograms. In another aspect, a bale comprises at least 15 kilograms. In another aspect, a bale comprises at least 20 kilograms. In another aspect, a bale comprises at least 25 kilograms. In another aspect, a bale comprises at least 30 kilograms. In another aspect, a bale comprises at least 35 kilograms. In another aspect, a bale comprises at least 40 kilograms. In another aspect, a bale comprises at least 45 kilograms. In another aspect, a bale comprises at least 50 kilograms. In another aspect, a bale comprises at least 60 kilograms. In another aspect, a bale comprises at least 70 kilograms. In another aspect, a bale comprises at least 80 kilograms. In another aspect, a bale comprises at least 90 kilograms. In another aspect, a bale comprises at least 100 kilograms. In another aspect, a bale comprises at least 125 kilograms. In another aspect, a bale comprises at least 150 kilograms. In another aspect, a bale comprises at least 175 kilograms. In another aspect, a bale comprises at least 200 kilograms. In another aspect, a bale comprises at least 225 kilograms. In another aspect, a bale comprises at least 250 kilograms. In another aspect, a bale comprises at least 275 kilograms. In another aspect, a bale comprises at least 300 kilograms. In another aspect, a bale comprises at least 350 kilograms. In another aspect, a bale comprises at least 400 kilograms. In another aspect, a bale comprises at least 450 kilograms. In another aspect, a bale comprises at least 500 kilograms. In another aspect, a bale comprises at least 600 kilograms. In another aspect, a bale comprises at least 700 kilograms. In another aspect, a bale comprises at least 800 kilograms. In another aspect, a bale comprises at least 900 kilograms. In another aspect, a bale comprises at least 1000 kilograms. In another aspect, a bale comprises at least 1500 kilograms. In another aspect, a bale comprises at least 2000 kilograms. A bale can be of any shape. Non-limiting examples of bale shapes include conical, spherical, rectangular, and cuboidal.

Also provided herein are containers of tobacco products from tobacco leaves harvested and cured from tobacco plants described herein. By way of non-limiting example, a container may be a box, a bag, a packet, a pack, a pouch, a tin, or any other container known in the art.

In one aspect, tobacco plants, seeds, plant components, plant cells, and plant genomes provided herein are from a tobacco type selected from the group consisting of flue-cured tobacco, sun-cured tobacco, air-cured tobacco, dark air-cured tobacco, and dark fire-cured tobacco. In another aspect, tobacco plants, seeds, plant components, plant cells, and plant genomes provided herein are from a tobacco type selected from the group consisting of Burley tobacco, Maryland tobacco, bright tobacco, Virginia tobacco, Oriental tobacco, Turkish tobacco, and Galpão tobacco. In one aspect, a tobacco plants or seed provided herein is a hybrid plants or seed. In one aspect, a tobacco plant provided herein is selected from the group consisting of a flue-cured variety tobacco plant, a bright variety tobacco plant, a Burley variety tobacco plant, a Virginia variety tobacco plant, a Maryland variety tobacco plant, a Galpão variety tobacco plant, a dark variety tobacco plant, an Oriental variety tobacco plant, and a Turkish variety tobacco plant.

As used herein, a “hybrid” is created by crossing two plants from different varieties or species, such that the progeny comprises genetic material from each parent. Skilled artisans recognize that higher order hybrids can be generated as well. For example, a first hybrid can be made by crossing Variety C with Variety D to create a C×D hybrid, and a second hybrid can be made by crossing Variety E with Variety F to create an E×F hybrid. The first and second hybrids can be further crossed to create the higher order hybrid (C×D)×(E×F) comprising genetic information from all four parent varieties. In an aspect, a tobacco plant provided herein is a hybrid tobacco plant. In another aspect, a tobacco seed provided herein is a hybrid tobacco seed.

In one aspect, a tobacco variety provided herein is male sterile. In another aspect, a tobacco variety provided herein is cytoplasmic male sterile (CMS). In an aspect, a tobacco plant provided herein is male sterile. In another aspect, a tobacco plant provided herein is cytoplasmic male sterile. Male sterile tobacco plants may be produced by any method known in the art. Methods of producing male sterile tobacco are described in Wernsman, E. A., and Rufty, R. C. 1987. Chapter Seventeen. Tobacco. Pages 669-698 In: Cultivar Development. Crop Species. W. H. Fehr (ed.), MacMillan Publishing Go., Inc., New York, N.Y. 761 pp. In another aspect, a tobacco variety provided herein is female sterile. As a non-limiting example, female sterile plants can be made by mutating the STIG1 gene. See, for example, Goldman et al. 1994, EMBO Journal 13:2976-2984. In an aspect, a tobacco plant provided herein is female sterile.

In one aspect, a tobacco variety provided herein is produced via haploid doubling. Haploid doubling occurs when a haploid line is induced to double its chromosome complement to a diploid state that is homozygous at all loci within the genome.

Flue-cured tobaccos (also called Virginia of bright tobaccos) amount to approximately 40% of world tobacco production. Flue-cured tobaccos are often also referred to as “bright tobacco” because of the golden-yellow to deep-orange color it reaches during curing. Flue-cured tobaccos have a light, bright aroma and taste. Flue-cured tobaccos are generally high in sugar and low in oils. Major flue-cured tobacco growing countries are Argentina, Brazil, China, India, Tanzania and the U.S. In one aspect, tobacco plants or seeds provided herein are in a flue-cured tobacco background selected from the group consisting of CC 13, CC 27, CC 33, CC35, CC 37, CC 65, CC 67, CC 700, GF 318, GL 338, GL 368, GL 939, K 346, K 399, K326, NC 102, NC 196, NC 291, NC 297, NC 299, NC 471, NC 55, NC 606, NC 71, NC 72, NC 92, PVH 1118, PVH 1452, PVH 2110, SPEIGHT 168, SPEIGHT 220, SPEIGHT 225, SPEIGHT 227, SPEIGHT 236, and any variety essentially derived from any one of the foregoing varieties. In another aspect, tobacco plants or seeds provided herein are in a flue-cured tobacco background selected from the group consisting of Coker 48, Coker 176, Coker 371-Gold, Coker 319, Coker 347, GL 939, K 149, K326, K 340, K 346, K 358, K 394, K 399, K 730, NC 27NF, NC 37NF, NC 55, NC 60, NC 71, NC 72, NC 82, NC 95, NC 297, NC 606, NC 729, NC 2326, McNair 373, McNair 944, Ox 207, Ox 414 NF, Reams 126, Reams 713, Reams 744, RG 8, RG 11, RG 13, RG 17, RG 22, RG 81, RG H4, RG H51, Speight H-20, Speight G-28, Speight G-58, Speight G-70, Speight G-108, Speight G-111, Speight G-117, Speight 168, Speight 179, Speight NF-3, Va 116, Va 182, and any variety essentially derived from any one of the foregoing varieties. See WO 2004/041006 A1. In further aspects, tobacco plants, seeds, hybrids, varieties, or lines provided herein are in any flue cured background selected from the group consisting of K326, K346, and NC196.

Air-cured tobaccos include Burley, Md., and dark tobaccos. The common factor is that curing is primarily without artificial sources of heat and humidity. Burley tobaccos are light to dark brown in color, high in oil, and low in sugar. Burley tobaccos are air-cured in barns. Major Burley growing countries are Argentina, Brazil, Italy, Malawi, and the U.S. Maryland tobaccos are extremely fluffy, have good burning properties, low nicotine and a neutral aroma. Major Maryland growing countries include the U.S. and Italy. In one aspect, tobacco plants or seeds provided herein are in a Burley tobacco background selected from the group consisting of Clay 402, Clay 403, Clay 502, Ky 14, Ky 907, Ky 910, Ky 8959, NC 2, NC 3, NC 4, NC 5, NC 2000, TN 86, TN 90, TN 97, R 610, R 630, R 711, R 712, NCBH 129, HB4488PLC, PD 7319LC, Bu 21×Ky 10, HB04P, Ky 14×L 8, Kt 200, Newton 98, Pedigo 561, Pf561 and Va 509. In further aspects, tobacco plants, seeds, hybrids, varieties, or lines provided herein are in any Burley background selected from the group consisting of TN 90, KT 209, KT 206, KT212, and HB 4488. In another aspect, tobacco plants or seeds provided herein are in a Maryland tobacco background selected from the group consisting of Md 10, Md 40, Md 201, Md 609, Md 872 and Md 341.

Dark air-cured tobaccos are distinguished from other types primarily by its curing process which gives dark air-cured tobacco its medium- to dark-brown color and distinct aroma. Dark air-cured tobaccos are mainly used in the production of chewing tobacco and snuff. In one aspect, tobacco plants or seeds provided herein are in a dark air-cured tobacco background selected from the group consisting of Sumatra, Jatim, Dominican Cubano, Besuki, One sucker, Green River, Va. sun-cured, and Paraguan Passado.

Dark fire-cured tobaccos are generally cured with low-burning wood fires on the floors of closed curing barns. Dark fire-cured tobaccos are used for making pipe blends, cigarettes, chewing tobacco, snuff and strong-tasting cigars. Major growing regions for dark fire-cured tobaccos are Tennessee, Kentucky, and Virginia, USA. In one aspect, tobacco plants or seeds provided herein are in a dark fire-cured tobacco background selected from the group consisting of Narrow Leaf Madole, Improved Madole, Tom Rosson Madole, Newton's VH Madole, Little Crittenden, Green Wood, Little Wood, Small Stalk Black Mammoth, DT 508, DT 518, DT 592, KY 171, DF 911, DF 485, TN D94, TN D950, VA 309, and VA 359.

Oriental tobaccos are also referred to as Greek, aroma and Turkish tobaccos due to the fact that they are typically grown in eastern Mediterranean regions such as Turkey, Greece, Bulgaria, Macedonia, Syria, Lebanon, Italy, and Romania. The small plant and leaf size, characteristic of today's Oriental varieties, as well as its unique aroma properties are a result of the plant's adaptation to the poor soil and stressful climatic conditions in which it develop over many past centuries. In one aspect, tobacco plants or seeds provided herein are in an Oriental tobacco background selected from the group consisting of Izmir, Katerini, Samsun, Basma and Krumovgrad, Trabzon, Thesalian, Tasova, Sinop, Izmit, Hendek, Edirne, Semdinli, Adiyanman, Yayladag, Iskenderun, Duzce, Macedonian, Mavra, Prilep, Bafra, Bursa, Bucak, Bitlis, Balikesir, and any variety essentially derived from any one of the foregoing varieties.

In one aspect, tobacco plants, seeds, hybrids, varieties, or lines provided herein are essentially derived from or in the genetic background of BU 64, CC 101, CC 200, CC 13, CC 27, CC 33, CC 35, CC 37, CC 65, CC 67, CC 301, CC 400, CC 500, CC 600, CC 700, CC 800, CC 900, CC 1063, Coker 176, Coker 319, Coker 371 Gold, Coker 48, CU 263, DF911, Galpão, GL 26H, GL 338, GL 350, GL 395, GL 600, GL 737, GL 939, GL 973, GF 157, GF 318, RJR 901, HB 04P, K 149, K 326, K 346, K 358, K394, K 399, K 730, NC 196, NC 37NF, NC 471, NC 55, NC 92, NC2326, NC 95, NC 925, PVH 1118, PVH 1452, PVH 2110, PVH 2254, PVH 2275, VA 116, VA 119, KDH 959, KT 200, KT204LC, KY 10, KY 14, KY 160, KY 17, KY 171, KY 907, KY 907LC, KTY14×L8 LC, Little Crittenden, McNair 373, McNair 944, male sterile KY 14×L8, Narrow Leaf Madole, MS KY171, Narrow Leaf Madole (phph), MS Narrow Leaf Madole, MS TND950, PD 7302LC, PD 7305LC, PD 7309LC, PD 7312LC, PD 7318LC, PD 7319LC, MSTKS 2002, TKF 2002, TKF 6400, TKF 4028, TKF 4024, KT206LC, KT209LC, KT210LC, KT212LC, NC 100, NC 102, NC 2000, NC 291, NC 297, NC 299, NC 3, NC 4, NC 5, NC 6, NC7, NC 606, NC 71, NC 72, NC 810, NC BH 129, NC 2002, Neal Smith Madole, OXFORD 207, ‘Perique’, PVH03, PVH09, PVH19, PVH50, PVH51, R 610, R 630, R 7-11, R 7-12, RG 17, RG 81, RG H51, RGH 4, RGH 51, RS 1410, Speight 168, Speight 172, Speight 179, Speight 210, Speight 220, Speight 225, Speight 227, Speight 234, Speight G-28, Speight G-70, Speight H-6, Speight H20, Speight NF3, TI 1406, TI 1269, TN 86, TN86LC, TN 90, TN90LC, TN 97, TN97LC, TN D94, TN D950, a TR (Tom Rosson) Madole, VA 309, VA 359, or any commercial tobacco variety according to standard tobacco breeding techniques known in the art.

In one aspect, a tobacco plant provided herein is selected from the group consisting of a BU 64 plant, a CC 101 plant, a CC 200 plant, a CC 13 plant, a CC 27 plant, a CC 33 plant, a CC 35 plant, a CC 37 plant, a CC 65 plant, a CC 67 plant, a CC 301 plant, a CC 400 plant, a CC 500 plant, CC 600 plant, a CC 700 plant, a CC 800 plant, a CC 900 plant, a CC 1063 plant, a Coker 176 plant, a Coker 319 plant, a Coker 371 Gold plant, a Coker 48 plant, a CU 263 plant, a DF911 plant, a Galpao plant, a GL 26H plant, a GL 338 plant, a GL 350 plant, a GL 395 plant, a GL 600 plant, a GL 737 plant, a GL 939 plant, a GL 973 plant, a GF 157 plant, a GF 318 plant, an RJR 901 plant, an HB 04P plant, a K 149 plant, a K 326 plant, a K 346 plant, a K 358 plant, a K394 plant, a K 399 plant, a K 730 plant, an NC 196 plant, an NC 37NF plant, an NC 471 plant, an NC 55 plant, an NC 92 plant, an NC2326 plant, an NC 95 plant, an NC 925 plant, a PVH 1118 plant, a PVH 1452 plant, a PVH 2110 plant, a PVH 2254 plant, a PVH 2275 plant, a VA 116 plant, a VA 119 plant, a KDH 959 plant, a KT 200 plant, a KT204LC plant, a KY 10 plant, a KY 14 plant, a KY 160 plant, a KY 17 plant, a KY 171 plant, a KY 907 plant, a KY 907LC plant, a KTY14×L8 LC plant, a Little Crittenden plant, a McNair 373 plant, a McNair 944 plant, a male sterile KY 14×L8 plant, a Narrow Leaf Madole plant, a MS KY171 plant, a Narrow Leaf Madole (phph) plant, a MS Narrow Leaf Madole plant, a MS TND950 plant, a PD 7302LC plant, a PD 7305LC plant, a PD 7309LC plant, a PD 7312LC plant, a PD 7318LC plant, a PD 7319LC plant, a MSTKS 2002 plant, a TKF 2002 plant, a TKF 6400 plant, a TKF 4028 plant, a TKF 4024 plant, a KT206LC plant, a KT209LC plant, a KT210LC plant, a KT212LC plant, an NC 100 plant, an NC 102 plant, an NC 2000 plant, an NC 291 plant, an NC 297 plant, an NC 299 plant, an NC 3 plant, an NC 4 plant, an NC 5 plant, an NC 6 plant, an NC7 plant, an NC 606 plant, an NC 71 plant, an NC 72 plant, an NC 810 plant, an NC BH 129 plant, an NC 2002 plant, a Neal Smith Madole plant, an OXFORD 207 plant, a ‘Perique’ plant, a PVH03 plant, a PVH09 plant, a PVH19 plant, a PVH50 plant, a PVH51 plant, an R 610 plant, an R 630 plant, an R 7-11 plant, an R 7-12 plant, an RG 17 plant, an RG 81 plant, an RG H51 plant, an RGH 4 plant, an RGH 51 plant, an RS 1410 plant, a Speight 168 plant, a Speight 172 plant, a Speight 179 plant, a Speight 210 plant, a Speight 220 plant, a Speight 225 plant, a Speight 227 plant, a Speight 234 plant, a Speight G-28 plant, a Speight G-70 plant, a Speight H-6 plant, a Speight H20 plant, a Speight NF3 plant, a TI 1406 plant, a TI 1269 plant, a TN 86 plant, a TN86LC plant, a TN 90 plant, a TN90LC plant, a TN 97 plant, a TN97LC plant, a TN D94 plant, a TN D950 plant, a TR (Tom Rosson) Madole plant, a VA 309 plant, and a VA 359 plant.

All foregoing mentioned specific varieties of dark air-cured, Burley, Md., dark fire-cured, or Oriental type are only listed for exemplary purposes. Any additional dark air-cured, Burley, Md., dark fire-cured, Oriental varieties are also contemplated in the present application.

In one aspect, this disclosure provides a method for controlling topping-induced suckers in a tobacco plant comprising: (a) introducing a nucleic acid molecule to a tobacco cell, where the nucleic acid molecule comprises a promoter active in axillary bud tissue, where the promoter: (i) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (ii) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (iii) is operably linked to a heterologous nucleic acid molecule encoding an axillary bud-degrading product; and (b) regenerating a tobacco plant from the tobacco cell, where the tobacco plant comprises no or reduced topping-induced suckers as compared to a control tobacco plant grown under comparable conditions.

Also provided herein are the transformation of tobacco plants with recombinant constructs or expression cassettes described herein using any suitable transformation methods known in the art. Methods for introducing polynucleotide sequences into tobacco plants are known in the art and include, but are not limited to, stable transformation methods, transient transformation methods, and virus-mediated methods. “Stable transformation” refers to transformation where the nucleotide construct of interest introduced into a plant integrates into a genome of the plant and is capable of being inherited by the progeny thereof. “Transient transformation” is intended to mean that a sequence is introduced into the plant and is only temporally expressed or is only transiently present in the plant.

In one aspect, methods and compositions provided herein comprise the introduction of one or more polynucleotides into one or more plant cells. In one aspect, a plant genome provided herein is modified to include an introduced nucleic acid molecule or recombinant vector. As used herein, “plant genome” refers to a nuclear genome, a mitochondrial genome, or a plastid (e.g., chloroplast) genome of a plant cell. In another aspect, a polynucleotide provided herein is integrated into an artificial chromosome. In one aspect, an artificial chromosome comprising a polynucleotide provided herein is integrated into a plant cell.

Suitable methods of introducing nucleic acid molecules (e.g., transgenes, recombinant vectors, recombinant DNA constructs, recombinant polynucleotides, expression constructs) into plant cells of the present disclosure include microinjection, electroporation, Agrobacterium-mediated transformation (U.S. Pat. Nos. 5,104,310, 5,149,645, 5,177,010, 5,231,019, 5,463,174, 5,464,763, 5,469,976, 4,762,785, 5,004,863, 5,159,135, 5,563,055, and 5,981,840), direct gene transfer, and ballistic particle acceleration (also known as biolistic delivery; see, for example, U.S. Pat. Nos. 4,945,050, 5,141,131, 5,886,244, 5,879,918, and 5,932,782). In an aspect, a method of introducing a nucleic acid molecule to a tobacco cell comprises Agrobacterium-mediated transformation. In another aspect, a method of introducing a nucleic acid molecule to a tobacco cell comprises electroporation. In an aspect, a method of introducing a nucleic acid molecule to a tobacco cell comprises Agrobacterium-mediated transformation. In an aspect, a method of introducing a nucleic acid molecule to a tobacco cell comprises biolistic delivery.

Nucleic acid molecules provided herein may be introduced into plants by contacting plants with a virus or viral nucleic acids. Generally, such methods involve incorporating an expression cassette of the present disclosure within a viral DNA or RNA molecule. It is recognized that promoters for use in the expression cassettes provided herein also encompass promoters utilized for transcription by viral RNA polymerases. Methods for introducing polynucleotides into plants and expressing a protein encoded therein, involving viral DNA or RNA molecules, are known in the art. See, for example, U.S. Pat. Nos. 5,889,191, 5,889,190, 5,866,785, 5,589,367, 5,316,931.

Any plant tissue that can be subsequently propagated using clonal methods, whether by organogenesis or embryogenesis, may be transformed with a recombinant construct or an expression cassette provided herein. By “organogenesis” in intended the process by which shoots and roots are developed sequentially from meristematic centers. By “embryogenesis” is intended the process by which shoots and roots develop together in a concerted fashion (not sequentially), whether from somatic cells or gametes. Exemplary tissues that are suitable for various transformation protocols described herein include, but are not limited to, protoplast cells, callus tissue, existing meristematic tissue (e.g., apical meristems, axillary buds, and root meristems) and induced meristem tissue (e.g., cotyledon meristem and hypocotyl meristem), hypocotyls, cotyledons, leaf disks, pollen, embryos, and the like. In one aspect, a transformed cell comprises a protoplast cell. In another aspect, a transformed cell comprises a callus cell.

In one aspect, this disclosure provides a method of growing a tobacco plant comprising planting a tobacco seed comprising a nucleic acid molecule, where the nucleic acid molecule comprises a promoter active in axillary bud tissue, where the promoter: (a) comprises a sequence having at least 75% identity to SEQ ID NO: 113, where the identity is based on, and limited to, the entire alignable region or regions between said sequence and SEQ ID NO: 113; (b) comprises a deletion of at least 50 contiguous nucleotides as compared to SEQ ID NO: 113; and (c) is operably linked to a heterologous nucleic acid molecule encoding an axillary bud-degrading product, where the tobacco seed germinates into a tobacco plant comprising no or reduced topping-induced suckers as compared to a control tobacco plant grown under comparable conditions.

As used herein, “planting” refers to providing a seed with conditions suitable to induce germination of the seed. In an aspect, a tobacco seed is planted in a field. In another aspect, a tobacco seed is planted in a greenhouse. In another aspect, a tobacco seed is planted in a growth chamber. In another aspect, a tobacco seed is planted in a laboratory. In another aspect, a tobacco seed is planted in a hydroponic growth system. In another aspect, a tobacco seed is planted in a pot. In an aspect, a tobacco seed is planted outdoors. In another aspect, a tobacco seed is planted indoors. In another aspect, a tobacco seed is planted in a growth medium. Non-limiting examples of growth medium include soil, clay, sand, loam, compost, manure, mulch, and combinations thereof.

The following exemplary, non-limiting embodiments are envisioned:

-   1. A nucleic acid molecule comprising a promoter active in axillary     bud tissue, wherein said promoter:     -   (a) comprises a sequence having at least 75% identity to SEQ ID         NO: 113, wherein said identity is based on, and limited to, the         entire alignable region or regions between said sequence and SEQ         ID NO: 113;     -   (b) comprises a deletion of at least 50 contiguous nucleotides         as compared to SEQ ID NO: 113; and     -   (c) is operably linked to a heterologous nucleic acid molecule. -   2. The nucleic acid molecule of embodiment 1, wherein said promoter     comprises between 50 nucleotides and 2450 nucleotides. -   3. The nucleic acid molecule of embodiment 1, wherein said promoter     comprises at least 50 nucleotides. -   4. The nucleic acid molecule of embodiment 1, wherein said promoter     comprises at least 500 nucleotides. -   5. The nucleic acid molecule of embodiment 1, wherein said promoter     comprises at least 1000 nucleotides. -   6. The nucleic acid molecule of embodiment 1, wherein said promoter     comprises at least 2000 nucleotides. -   7. The nucleic acid molecule of any one of embodiments 1 to 6,     wherein said promoter comprises two or fewer sugar repressive     elements. -   8. The nucleic acid molecule of any one of embodiments 1 to 6,     wherein said deletion comprises the deletion of at least one sugar     repressive element. -   9. The nucleic acid molecule of any one of embodiments 1 to 6,     wherein said deletion comprises the deletion of at least two sugar     repressive elements. -   10. The nucleic acid molecule of any one of embodiments 1 to 9,     wherein said deletion comprises the deletion of an axillary bud up2     element. -   11. The nucleic acid molecule of any one of embodiments 1 to 10,     wherein said deletion comprises the deletion of at least one sugar     repressive element and at least one axillary bud up2 element. -   12. The nucleic acid molecule of any one of embodiments 1 to 11,     wherein said deletion comprises the deletion of at least one bud     dormancy element. -   13. The nucleic acid molecule of any one of embodiments 1 to 12,     wherein said deletion comprises the deletion of at least 75     contiguous nucleotides as compared to SEQ ID NO: 113. -   14. The nucleic acid molecule of any one of embodiments 1 to 13,     wherein said deletion comprises the deletion of at least 100     contiguous nucleotides as compared to SEQ ID NO: 113. -   15. The nucleic acid molecule of any one of embodiments 1 to 14,     wherein said deletion comprises the deletion of at least 200     contiguous nucleotides as compared to SEQ ID NO: 113. -   16. The nucleic acid molecule of any one of embodiments 1 to 15,     wherein said deletion comprises the deletion of at least 500     contiguous nucleotides as compared to SEQ ID NO: 113. -   17. The nucleic acid molecule of any one of embodiments 1 to 16,     wherein said promoter comprises a nucleic acid sequence at least 85%     identical to SEQ ID NO: 257. -   18. The nucleic acid molecule of any one of embodiments 1 to 17,     wherein said heterologous nucleic acid molecule encodes at least one     axillary bud-degrading product. -   19. The nucleic acid molecule of embodiment 18, wherein said at     least one axillary bud-degrading product is selected from the group     consisting of a small RNA molecule and a polypeptide. -   20. The nucleic acid molecule of embodiment 19, wherein said     polypeptide comprises an amino acid sequence at least 70% identical     or similar to an amino acid sequence selected from the group     consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22,     24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58,     60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193,     195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220,     222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249,     251, 253, and 255. -   21. The nucleic acid molecule of embodiment 19, wherein said small     RNA molecule comprises at least 18 contiguous nucleotides identical     or complementary to a polynucleotide selected from the group     consisting of SEQ ID NOs: 83-101. -   22. A tobacco plant comprising a nucleic acid molecule comprising a     promoter active in axillary bud tissue, wherein said promoter:     -   (a) comprises a sequence having at least 75% identity to SEQ ID         NO: 113, wherein said identity is based on, and limited to, the         entire alignable region or regions between said sequence and SEQ         ID NO: 113;     -   (b) comprises a deletion of at least 50 contiguous nucleotides         as compared to SEQ ID NO: 113; and     -   (c) is operably linked to a heterologous nucleic acid molecule,     -   wherein said tobacco plant comprises no suckers or reduced         suckers after topping as compared to a control tobacco plant of         the same variety when grown under comparable conditions. -   23. The tobacco plant of embodiment 22, wherein said promoter     comprises between 50 nucleotides and 2450 nucleotides. -   24. The tobacco plant of embodiment 22, wherein said promoter     comprises at least 50 nucleotides. -   25. The tobacco plant of embodiment 22, wherein said promoter     comprises at least 500 nucleotides. -   26. The tobacco plant of embodiment 22, wherein said promoter     comprises at least 1000 nucleotides. -   27. The tobacco plant of embodiment 22, wherein said promoter     comprises at least 2000 nucleotides. -   28. The tobacco plant of any one of embodiments 22 to 27, wherein     said promoter comprises two or fewer sugar repressive elements. -   29. The tobacco plant of any one of embodiments 22 to 27, wherein     said deletion comprises the deletion of at least one sugar     repressive element. -   30. The tobacco plant of any one of embodiments 22 to 27, wherein     said deletion comprises the deletion of at least two sugar     repressive elements. -   31. The tobacco plant of any one of embodiments 22 to 30, wherein     said deletion comprises the deletion of an axillary bud up2 element. -   32. The tobacco plant of any one of embodiments 22 to 31, wherein     said deletion comprises the deletion of at least one sugar     repressive element and at least one axillary bud up2 element. -   33. The tobacco plant of any one of embodiments 22 to 32, wherein     said deletion comprises the deletion of at least one bud dormancy     element. -   34. The tobacco plant of any one of embodiments 22 to 33, wherein     said deletion comprises the deletion of at least 75 contiguous     nucleotides as compared to SEQ ID NO: 113. -   35. The tobacco plant of any one of embodiments 22 to 34, wherein     said deletion comprises the deletion of at least 100 contiguous     nucleotides as compared to SEQ ID NO: 113. -   36. The tobacco plant of any one of embodiments 22 to 35, wherein     said deletion comprises the deletion of at least 200 contiguous     nucleotides as compared to SEQ ID NO: 113. -   37. The tobacco plant of any one of embodiments 22 to 36, wherein     said deletion comprises the deletion of at least 500 contiguous     nucleotides as compared to SEQ ID NO: 113. -   38. The tobacco plant of any one of embodiments 22 to 37, wherein     said promoter comprises a nucleic acid sequence at least 85%     identical to SEQ ID NO: 257. -   39. The tobacco plant of any one of embodiments 22 to 38, wherein     said promoter is active in axillary meristem tissue. -   40. The tobacco plant of any one of embodiments 22 to 39, wherein     said promoter is active in axillary meristem tissue at least 7 days     after said topping. -   41. The tobacco plant of any one of embodiments 22 to 40, wherein     said promoter is not active in a seedling tobacco plant. -   42. The tobacco plant of any one of embodiments 22 to 41, wherein     said promoter is not active in shoot apical meristem tissue. -   43. The tobacco plant of any one of embodiments 22 to 42, wherein     said no suckers or reduced suckers is measured one week after said     topping. -   44. The tobacco plant of any one of embodiments 22 to 43, wherein     said no suckers or reduced suckers is measured four weeks after said     topping. -   45. The tobacco plant of any one of embodiments 22 to 44, wherein     said reduced suckers comprises at least 10% fewer suckers. -   46. The tobacco plant of any one of embodiments 22 to 45, wherein     said reduced suckers comprises reduced dry biomass of the suckers,     reduced fresh weight of the suckers, reduced length of the suckers,     reduced diameter of the suckers, reduced number of total suckers, or     any combination thereof. -   47. The tobacco plant of any one of embodiments 22 to 46, wherein     said tobacco plant comprises a higher leaf yield mass as compared to     said control tobacco plant. -   48. The tobacco plant of any one of embodiments 22 to 47, wherein     said tobacco plant comprises a height that is equal to or greater     than the height of said control plant. -   49. The tobacco plant of any one of embodiments 22 to 48, wherein     said tobacco plant is selected from the group consisting a BU 64     plant, a CC 101 plant, a CC 200 plant, a CC 13 plant, a CC 27 plant,     a CC 33 plant, a CC 35 plant, a CC 37 plant, a CC 65 plant, a CC 67     plant, a CC 301 plant, a CC 400 plant, a CC 500 plant, CC 600 plant,     a CC 700 plant, a CC 800 plant, a CC 900 plant, a CC 1063 plant, a     Coker 176 plant, a Coker 319 plant, a Coker 371 Gold plant, a Coker     48 plant, a CU 263 plant, a DF911 plant, a Galpao plant, a GL 26H     plant, a GL 338 plant, a GL 350 plant, a GL 395 plant, a GL 600     plant, a GL 737 plant, a GL 939 plant, a GL 973 plant, a GF 157     plant, a GF 318 plant, an RJR 901 plant, an HB 04P plant, a K 149     plant, a K 326 plant, a K 346 plant, a K 358 plant, a K394 plant, a     K 399 plant, a K 730 plant, an NC 196 plant, an NC 37NF plant, an NC     471 plant, an NC 55 plant, an NC 92 plant, an NC2326 plant, an NC 95     plant, an NC 925 plant, a PVH 1118 plant, a PVH 1452 plant, a PVH     2110 plant, a PVH 2254 plant, a PVH 2275 plant, a VA 116 plant, a VA     119 plant, a KDH 959 plant, a KT 200 plant, a KT204LC plant, a KY 10     plant, a KY 14 plant, a KY 160 plant, a KY 17 plant, a KY 171 plant,     a KY 907 plant, a KY 907LC plant, a KTY14×L8 LC plant, a Little     Crittenden plant, a McNair 373 plant, a McNair 944 plant, a male     sterile KY 14×L8 plant, a Narrow Leaf Madole plant, a MS KY171     plant, a Narrow Leaf Madole (phph) plant, a MS Narrow Leaf Madole     plant, a MS TND950 plant, a PD 7302LC plant, a PD 7305LC plant, a PD     7309LC plant, a PD 7312LC plant, a PD 7318LC plant, a PD 7319LC     plant, a MSTKS 2002 plant, a TKF 2002 plant, a TKF 6400 plant, a TKF     4028 plant, a TKF 4024 plant, a KT206LC plant, a KT209LC plant, a     KT210LC plant, a KT212LC plant, an NC 100 plant, an NC 102 plant, an     NC 2000 plant, an NC 291 plant, an NC 297 plant, an NC 299 plant, an     NC 3 plant, an NC 4 plant, an NC 5 plant, an NC 6 plant, an NC7     plant, an NC 606 plant, an NC 71 plant, an NC 72 plant, an NC 810     plant, an NC BH 129 plant, an NC 2002 plant, a Neal Smith Madole     plant, an OXFORD 207 plant, a ‘Perique’ plant, a PVH03 plant, a     PVH09 plant, a PVH19 plant, a PVH50 plant, a PVH51 plant, an R 610     plant, an R 630 plant, an R 7-11 plant, an R 7-12 plant, an RG 17     plant, an RG 81 plant, an RG H51 plant, an RGH 4 plant, an RGH 51     plant, an RS 1410 plant, a Speight 168 plant, a Speight 172 plant, a     Speight 179 plant, a Speight 210 plant, a Speight 220 plant, a     Speight 225 plant, a Speight 227 plant, a Speight 234 plant, a     Speight G-28 plant, a Speight G-70 plant, a Speight H-6 plant, a     Speight H20 plant, a Speight NF3 plant, a TI 1406 plant, a TI 1269     plant, a TN 86 plant, a TN86LC plant, a TN 90 plant, a TN90LC plant,     a TN 97 plant, a TN97LC plant, a TN D94 plant, a TN D950 plant, a TR     (Tom Rosson) Madole plant, a VA 309 plant, and a VA 359 plant. -   50. The tobacco plant of any one of embodiments 22 to 49, wherein     said tobacco plant is selected from the group consisting of a     flue-cured variety tobacco plant, a bright variety tobacco plant, a     Burley variety tobacco plant, a Virginia variety tobacco plant, a     Maryland variety tobacco plant, a Galpão variety tobacco plant, a     dark variety tobacco plant, an Oriental variety tobacco plant, and a     Turkish variety tobacco plant. -   51. The tobacco plant of any one of embodiments 22 to 50, wherein     said tobacco plant is a hybrid tobacco plant. -   52. The tobacco plant of any one of embodiments 22 to 51, wherein     said tobacco plant is a female sterile tobacco plant. -   53. The tobacco plant of any one of embodiments 22 to 52, wherein     said tobacco plant is a male sterile tobacco plant. -   54. The tobacco plant of embodiment 53, wherein said male sterile     tobacco plant is a cytoplasmically male sterile tobacco plant. -   55. The tobacco plant of any one of embodiments 22 to 54, wherein     said heterologous nucleic acid molecule encodes at least one     axillary bud-degrading product. -   56. The tobacco plant of embodiment 55, wherein said at least one     axillary bud-degrading product is selected from the group consisting     of a small RNA molecule and a polypeptide. -   57. The tobacco plant of embodiment 56, wherein said polypeptide     comprises an amino acid sequence at least 70% identical or similar     to an amino acid sequence selected from the group consisting of SEQ     ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32,     34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72,     74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201,     203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231,     233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. -   58. The tobacco plant of embodiment 56, wherein said small RNA     molecule comprises at least 18 contiguous nucleotides identical or     complementary to a polynucleotide selected from the group consisting     of SEQ ID NOs: 83-101. -   59. A tobacco leaf of the tobacco plant of any one of embodiments 22     to 58. -   60. A tobacco product comprising cured tobacco material from the     tobacco plant of any one of embodiments 22 to 58. -   61. A tobacco product comprising an alkaloid extracted from the     tobacco plant, or a part thereof, of claim 22. -   62. The tobacco product of claim 60 or 61, wherein said alkaloid is     selected from the group consisting of nicotine, nornicotine,     anatabine, and anabasine. -   63. The tobacco product of embodiment 60, wherein said tobacco     product is selected from the group consisting of a cigarette, a     kretek, a bidi cigarette, a cigar, a cigarillo, a non-ventilated     cigarette, a vented recess filter cigarette, pipe tobacco, snuff,     chewing tobacco, moist smokeless tobacco, fine cut chewing tobacco,     long cut chewing tobacco, and pouched chewing tobacco product. -   64. The tobacco product of embodiment 60, wherein said tobacco     product is selected from the group consisting of a gum, a tablet, a     lozenge, and a dissolving strip. -   65. The tobacco product of any one of embodiments 60 to 64, wherein     said tobacco product is a smokeless tobacco product. -   66. The tobacco product of claim 61 or 62, wherein said tobacco     product is selected from the group consisting of an electronic     cigarette, an electronic smoking article, an aerosolized vapor     product, and a heated tobacco product. -   67. The tobacco product of any one of embodiments 60 or 62 to 66,     wherein said cured tobacco material is selected from the group     consisting of air-cured tobacco material, fire-cured tobacco     material, sun-cured tobacco material, and flue-cured tobacco     material. -   68. A plant or seed comprising a nucleic acid molecule, wherein said     nucleic acid molecule comprises a promoter active in axillary bud     tissue, wherein said promoter:     -   (a) comprises a sequence having at least 75% identity to SEQ ID         NO: 113, wherein said identity is based on, and limited to, the         entire alignable region or regions between said sequence and SEQ         ID NO: 113;     -   (b) comprises a deletion of at least 50 contiguous nucleotides         as compared to SEQ ID NO: 113; and     -   (c) is operably linked to a heterologous nucleic acid molecule         encoding an axillary bud-degrading product. -   69. The plant or seed of embodiment 68, wherein said promoter     comprises between 50 nucleotides and 2450 nucleotides. -   70. The plant or seed of embodiment 68, wherein said promoter     comprises at least 50 nucleotides. -   71. The plant or seed of embodiment 68, wherein said promoter     comprises at least 500 nucleotides. -   72. The plant or seed of embodiment 68, wherein said promoter     comprises at least 1000 nucleotides. -   73. The plant or seed of embodiment 68, wherein said promoter     comprises at least 2000 nucleotides. -   74. The plant or seed of any one of embodiments 68 to 73, wherein     said promoter comprises a nucleic acid sequence at least 85%     identical to SEQ ID NO: 257. -   75. The plant or seed of any one of embodiments 68 to 73, wherein     said plant or seed is a tobacco plant or a tobacco seed. -   76. The plant of any one of embodiments 68 to 74, wherein said plant     comprises no or reduced suckers as compared to a control plant when     grown under comparable conditions. -   77. The plant or seed of any one of embodiments 68 to 75, wherein     said axillary bud-degrading product is selected from the group     consisting of a small RNA molecule and a polypeptide. -   78. The plant or seed of embodiment 77, wherein said polypeptide     comprises an amino acid sequence at least 70% identical or similar     to an amino acid sequence selected from the group consisting of SEQ     ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32,     34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72,     74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201,     203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231,     233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. -   79. The plant or seed of embodiment 77, wherein said small RNA     molecule comprises at least 18 contiguous nucleotides identical or     complementary to a polynucleotide selected from the group consisting     of SEQ ID NOs: 83-101. -   80. A method for controlling topping-induced suckers in a tobacco     plant comprising:     -   (a) introducing a nucleic acid molecule to a tobacco cell,         wherein said nucleic acid molecule comprises a promoter active         in axillary bud tissue, wherein said promoter:         -   (i) comprises a sequence having at least 75% identity to SEQ             ID NO: 113, wherein said identity is based on, and limited             to, the entire alignable region or regions between said             sequence and SEQ ID NO: 113;         -   (ii) comprises a deletion of at least 50 contiguous             nucleotides as compared to SEQ ID NO: 113; and         -   (iii) is operably linked to a heterologous nucleic acid             molecule encoding an axillary bud-degrading product; and     -   (b) regenerating a tobacco plant from said tobacco cell, wherein         said tobacco plant comprises no or reduced topping-induced         suckers as compared to a control tobacco plant grown under         comparable conditions. -   81. The method of embodiment 80, wherein said introducing comprises     Agrobacterium-mediated transformation. -   82. The method of embodiment 80, wherein said introducing comprises     electroporation. -   83. The method of embodiment 80, wherein said introducing comprises     biolistic delivery of said nucleic acid molecule. -   84. The method of any one of embodiments 80 to 83, wherein said     tobacco cell is a protoplast cell. -   85. The method of any one of embodiments 80 to 83, wherein said     tobacco cell is a callus cell. -   86. The method of any one of embodiments 80 to 83, wherein said     tobacco cell is selected from the group consisting of a seed cell, a     fruit cell, a leaf cell, a cotyledon cell, a hypocotyl cell, a     meristem cell, an embryo cell, an endosperm cell, a root cell, a     shoot cell, a stem cell, a flower cell, an inflorescence cell, a     stalk cell, a pedicel cell, a style cell, a stigma cell, a     receptacle cell, a petal cell, a sepal cell, a pollen cell, an     anther cell, a filament cell, an ovary cell, an ovule cell, a     pericarp cell, and a phloem cell. -   87. A method of growing a tobacco plant comprising planting a     tobacco seed comprising a nucleic acid molecule, wherein said     nucleic acid molecule comprises a promoter active in axillary bud     tissue, wherein said promoter:     -   (a) comprises a sequence having at least 75% identity to SEQ ID         NO: 113, wherein said identity is based on, and limited to, the         entire alignable region or regions between said sequence and SEQ         ID NO: 113;     -   (b) comprises a deletion of at least 50 contiguous nucleotides         as compared to SEQ ID NO: 113; and     -   (c) is operably linked to a heterologous nucleic acid molecule         encoding an axillary bud-degrading product,     -   wherein said tobacco seed germinates into a tobacco plant         comprising no or reduced topping-induced suckers as compared to         a control tobacco plant grown under comparable conditions. -   88. The method of any one of embodiments 80 to 87, wherein said     promoter comprises between 50 nucleotides and 2450 nucleotides. -   89. The method of any one of embodiments 80 to 87, wherein said     promoter comprises at least 50 nucleotides. -   90. The method of any one of embodiments 80 to 87, wherein said     promoter comprises at least 500 nucleotides. -   91. The method of any one of embodiments 80 to 87, wherein said     promoter comprises at least 1000 nucleotides. -   92. The method of any one of embodiments 80 to 87, wherein said     promoter comprises at least 2000 nucleotides. -   93. The method of any one of embodiments 80 to 92, wherein said     promoter comprises a nucleic acid sequence at least 85% identical to     SEQ ID NO: 257. -   94. The method of any one of embodiments 80 to 93, wherein said     tobacco plant is selected from the group consisting a BU 64 plant, a     CC 101 plant, a CC 200 plant, a CC 13 plant, a CC 27 plant, a CC 33     plant, a CC 35 plant, a CC 37 plant, a CC 65 plant, a CC 67 plant, a     CC 301 plant, a CC 400 plant, a CC 500 plant, CC 600 plant, a CC 700     plant, a CC 800 plant, a CC 900 plant, a CC 1063 plant, a Coker 176     plant, a Coker 319 plant, a Coker 371 Gold plant, a Coker 48 plant,     a CU 263 plant, a DF911 plant, a Galpao plant, a GL 26H plant, a GL     338 plant, a GL 350 plant, a GL 395 plant, a GL 600 plant, a GL 737     plant, a GL 939 plant, a GL 973 plant, a GF 157 plant, a GF 318     plant, an RJR 901 plant, an HB 04P plant, a K 149 plant, a K 326     plant, a K 346 plant, a K 358 plant, a K394 plant, a K 399 plant, a     K 730 plant, an NC 196 plant, an NC 37NF plant, an NC 471 plant, an     NC 55 plant, an NC 92 plant, an NC2326 plant, an NC 95 plant, an NC     925 plant, a PVH 1118 plant, a PVH 1452 plant, a PVH 2110 plant, a     PVH 2254 plant, a PVH 2275 plant, a VA 116 plant, a VA 119 plant, a     KDH 959 plant, a KT 200 plant, a KT204LC plant, a KY 10 plant, a KY     14 plant, a KY 160 plant, a KY 17 plant, a KY 171 plant, a KY 907     plant, a KY 907LC plant, a KTY14×L8 LC plant, a Little Crittenden     plant, a McNair 373 plant, a McNair 944 plant, a male sterile KY     14×L8 plant, a Narrow Leaf Madole plant, a MS KY171 plant, a Narrow     Leaf Madole (phph) plant, a MS Narrow Leaf Madole plant, a MS TND950     plant, a PD 7302LC plant, a PD 7305LC plant, a PD 7309LC plant, a PD     7312LC plant, a PD 7318LC plant, a PD 7319LC plant, a MSTKS 2002     plant, a TKF 2002 plant, a TKF 6400 plant, a TKF 4028 plant, a TKF     4024 plant, a KT206LC plant, a KT209LC plant, a KT210LC plant, a     KT212LC plant, an NC 100 plant, an NC 102 plant, an NC 2000 plant,     an NC 291 plant, an NC 297 plant, an NC 299 plant, an NC 3 plant, an     NC 4 plant, an NC 5 plant, an NC 6 plant, an NC7 plant, an NC 606     plant, an NC 71 plant, an NC 72 plant, an NC 810 plant, an NC BH 129     plant, an NC 2002 plant, a Neal Smith Madole plant, an OXFORD 207     plant, a ‘Perique’ plant, a PVH03 plant, a PVH09 plant, a PVH19     plant, a PVH50 plant, a PVH51 plant, an R 610 plant, an R 630 plant,     an R 7-11 plant, an R 7-12 plant, an RG 17 plant, an RG 81 plant, an     RG H51 plant, an RGH 4 plant, an RGH 51 plant, an RS 1410 plant, a     Speight 168 plant, a Speight 172 plant, a Speight 179 plant, a     Speight 210 plant, a Speight 220 plant, a Speight 225 plant, a     Speight 227 plant, a Speight 234 plant, a Speight G-28 plant, a     Speight G-70 plant, a Speight H-6 plant, a Speight H20 plant, a     Speight NF3 plant, a TI 1406 plant, a TI 1269 plant, a TN 86 plant,     a TN86LC plant, a TN 90 plant, a TN90LC plant, a TN 97 plant, a     TN97LC plant, a TN D94 plant, a TN D950 plant, a TR (Tom Rosson)     Madole plant, a VA 309 plant, and a VA 359 plant. -   95. The method of any one of embodiments 80 to 93, wherein said     tobacco plant is selected from the group consisting of a flue-cured     variety tobacco plant, a bright variety tobacco plant, a Burley     variety tobacco plant, a Virginia variety tobacco plant, a Maryland     variety tobacco plant, a Galpão variety tobacco plant, a dark     variety tobacco plant, an Oriental variety tobacco plant, and a     Turkish variety tobacco plant. -   96. The method of any one of embodiments 80 to 95, wherein said     tobacco plant is a hybrid tobacco plant. -   97. The method of any one of embodiments 80 to 95, wherein said     tobacco plant is a female sterile tobacco plant. -   98. The method of any one of embodiments 80 to 97, wherein said     tobacco plant is a male sterile tobacco plant. -   99. The method of embodiment 95, wherein said male sterile tobacco     plant is a cytoplasmically male sterile tobacco plant. -   100. The method of any one of embodiments 80 to 99, wherein said     axillary bud-degrading product is selected from the group consisting     of a small RNA molecule and a polypeptide. -   101. The method of embodiment 100, wherein said polypeptide     comprises an amino acid sequence at least 70% identical or similar     to an amino acid sequence selected from the group consisting of SEQ     ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32,     34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72,     74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201,     203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231,     233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and 255. -   102. The method of embodiment 100, wherein said small RNA molecule     comprises at least 18 contiguous nucleotides identical or     complementary to a polynucleotide selected from the group consisting     of SEQ ID NOs: 83-101.

EXAMPLES Example 1. Development of Tobacco Plants

An expression vector, p45-2-7 (SEQ ID NO: 112; FIG. 1 ), is used as a backbone to generate multiple transformation vectors. p45-2-7 contains a CsVMV promoter, a NOS terminator, and a cassette comprising a kanamycin selection marker (NPT II) operably linked to an Actin2 promoter and a NOS terminator. Nucleic acid vectors comprising transgenes of interest are introduced into tobacco leaf discs via Agrobacterium transformation. See, for example, Mayo et al., 2006, Nat Protoc. 1:1105-11 and Horsch et al., 1985, Science 227:1229-1231.

Narrow Leaf Madole (NLM) tobacco plants are grown in Magenta™ GA-7 boxes and leaf discs are cut and placed into Petri plates. Agrobacterium tumefaciens cells comprising a transformation vector are collected by centrifuging a 20 mL cell suspension in a 50 mL centrifuge tube at 3500 RPM for 10 minutes. The supernatant is removed and the Agrobacterium tumefaciens cell pellet is re-suspended in 40 mL liquid re-suspension medium. Tobacco leaves, avoiding the midrib, are cut into eight 0.6 cm discs with a #15 razor blade and placed upside down in a Petri plate. A thin layer of Murashige & Skoog (MS) with B5 vitamins liquid re-suspension medium is added to the Petri plate and the leaf discs are poked uniformly with a fine point needle. About 25 mL of the Agrobacterium tumefaciens suspension is added to the Petri plate and the leaf discs are incubated in the suspension for 10 minutes.

Leaf discs are transferred to co-cultivation Petri plates (1/2 MS medium) and discs are placed upside down in contact with filter paper overlaid on the co-cultivation TOM medium (MS medium with 20 g/L sucrose; 1 mg/L indole-3-acetic acid; and 2.5 mg/L 6-benzyl aminopurine (BAP)). The Petri plate is sealed with parafilm prior to incubation in dim light (60-80 mE/ms) with 18 hours on, 6 hours off photoperiods at 24 degrees Celsius for three days. After incubation, leaf discs are transferred to regeneration/selection TOM K medium Petri plates (TOM medium plus 300 mg/L kanamycin). Leaf discs are sub-cultured bi-weekly to fresh TOM K medium in dim light with 18 hours on, 6 hours off photoperiods at 24 degrees Celsius until shoots become excisable. Shoots from leaves are removed with forceps and inserted in MS basal medium with 100 mg/L kanamycin. Shoots on MS basal medium with 100 mg/L kanamycin are incubated at 24 degrees Celsius with 18 hours on, 6 hours off photoperiods with high intensity lighting (6080 mE/ms) to induce rooting.

When plantlets containing both shoots and roots grow large enough (e.g., reach approximately half the height of a Magenta™ GA-7 box), they are transferred to soil. Established seedlings are transferred to a greenhouse for further analysis and to set seed. Evaluation of suckering phenotypes is conducted by growing modified plants (T0, T1, T2, or later generations) and control plants to layby stage. Control plants are either NLM plants that have not been transformed or NLM plants that have been transformed with an empty p45-2-7 vector. Plants that have reached layby stage are manually topped (the shoot apical meristem and surrounding tissue is removed), and axillary bud growth is evaluated at specific time points after topping. Observations are typically performed at the time of topping (i.e., 0 hours), 24 hours (i.e., 1 day) after topping, 7-8 days after topping (i.e., one week), and/or 14-15 days (i.e., two weeks) after topping. Observations comprise qualitatively examining the presence or absence of axillary bud growth and overall plant appearance. Observations also comprise quantitatively measuring the fresh weight of all axillary buds at a specific time point after topping and/or measuring the length of all axillary bud outgrowths at a specific time point after topping.

Example 2. Expression Pattern of Axillary Bud-Preferred Promoters

As noted in U.S. Patent Application Publication 2017/0260535, which is incorporated herein by reference, expression of axillary bud-degrading products can be better utilized to reduce or eliminate sucker outgrowth in modified plants if the axillary bud-degrading products are expressed in a tissue-dependent manner (e.g., only in the axillary bud). SEQ ID NO: 113 was previously identified as a promoter having axillary bud-preferred expression. See US 2017/0260535. The sequence of promoter P1 (SEQ ID NO: 113) comprises several cis-regulatory elements, including three sugar repressive elements, one axillary bud up2 element, and three bud dormancy elements. See FIG. 2 and Table 2. SEQ ID NO: 257 is identical to SEQ ID NO: 113, except for a 100 nucleotide deletion from the 5′ end of the sequence, which includes a deletion of one sugar repressive element. See FIG. 2 .

TABLE 2  Axillary bud-preferred promoter cis-elements Cis-regulatory  Cis-regulatory element  element Name Nucleotide Sequence Bud Dormancy Element CACGTG (SEQ ID NO: 258) Sugar Repressive Element TTATCC (SEQ ID NO: 259) Axillary Bud Growth Up2  AAACCCTA (SEQ ID NO: 260) Element

Expression patterns of SEQ ID NOs: 113 and 257 are analyzed by transformation of tobacco with a chimeric promoter:: . . . -glucuronidase (GUS) reporter gene within the same plasmid backbone (p45-2-′7) described in Example 1. The chimeric gene is introduced via Agrobacterium-mediated transformation into an NLM line. GUS staining is used to identify tissue-specific promoter expression following the method of Crone et al., 2001, Plant Cell Environ. 24:869-874.

Briefly, tissue from young seedlings comprising a candidate promoter::GUS transformation construct is placed in cold 90% acetone on ice. When all samples are harvested, samples are placed at room temperature for 20 minutes. Samples are placed back on ice and acetone is removed from the samples. Next, staining buffer (0.2% Triton X-100; 50 mM NaHPO₄, pH7.2; 2 mM potassium ferrocyanide) is added to the samples. X-Gluc is added to the staining buffer to a final concentration of 2 mM. Staining buffer is removed from the samples and fresh staining buffer with X-Gluc is added. The samples are then infiltrated under vacuum, on ice, for 15 to 20 minutes. The samples are incubated at 37 degrees Celsius for 2-18 hours before the staining buffer is removed. Samples are washed through an ethanol series (i.e., 10%, 30%, 50%, 70%, 95%) in the dark for 30 minutes per wash. Finally, samples are transferred into 100% ethanol.

GUS-positive plant tissues are examined with a bright-field microscope (Leica Q500MC; Cambridge, England) at a low magnification and photographed with a digital camera. Results of experiments using SEQ ID NOs: 113 and 257 are shown in FIGS. 3 and 4 respectively. Two independent modified lines are shown in FIG. 4 for SEQ ID NO: 257. These promoter sequences can be used to drive the expression of a sequence of interest exclusively, or predominantly, within an axillary bud while limiting expression in the rest of the plant.

GUS-positive expression, indicating expression driven by SEQ ID NOs: 113 and 257, is concentrated in axillary buds. Neither promoter appears to be active in seedlings (FIG. 5 ), and SEQ ID NO: 113 is not active in stigmas or anthers (FIG. 6 ). The expression of GUS under the direction of SEQ ID NO: 113 decreases after topping, which coincides with the gene expression pattern that is observed for the endogenous genes that is normally regulated by these promoters. However, expression of GUS under the direction of SEQ ID NO: 257 is stronger and persists at a higher level for a greater period of time as compared to SEQ ID NO: 113. Notably, as shown in FIG. 3 , little GUS expression is observed in axillary meristems seven days after topping when driven by SEQ ID NO: 113, even when stained for 24 hours. In contrast, both modified lines using SEQ ID NO: 257 to drive GUS expression still show strong activity seven days after topping, even when stained for only 5 to 7 hours (FIG. 4 ).

Example 3. Axillary Bud-Preferred Promoters Driving the Expression of Barnase

Two constructs were created as described in Examples 1 and 2, with either SEQ ID NO: 113 or SEQ ID NO: 257 driving the expression of Barnase (SEQ ID NO: 79). Tobacco plants were generated as described in Example 1.

Tobacco plants (T0 generation) comprising SEQ ID NO: 113 driving the expression of Barnase and control tobacco plants are grown to the layby stage, then plants are topped to remove the shoot apical meristem. Sucker growth is observed at the time of topping and two weeks after topping (FIG. 7 ). Plants expressing the SEQ ID NO: 113::Barnase construct exhibit a reduction of suckers as compared to the control. However, the T1 generation seeds of SEQ ID NO: 113::Barnase lines exhibit poor germination, precluding further phenotypic analysis.

In contrast, T1 generation seed comprising SEQ ID NO: 257 driving the expression of Barnase exhibit good germination. Tobacco plants (T1 generation) comprising SEQ ID NO: 257 driving the expression of Barnase and control tobacco plants are grown to the layby stage, then plants are topped to remove the shoot apical meristem. Sucker grown is observed at the time of topping and four weeks after topping (FIG. 8 ). Plants expressing the SEQ ID NO: 257::Barnase construct exhibit a reduction in suckers as compared to the control. Modified plants comprising the SEQ ID NO: 257::Barnase construct demonstrate superior reduction of suckers and superior T1 seed germination as compared to modified plants comprising the SEQ ID NO: 113::Barnase construct. 

The invention claimed is:
 1. Cured tobacco material comprising a DNA construct, wherein the DNA construct comprises a promoter comprising the nucleic acid sequence of SEQ ID NO: 257 operably linked to a heterologous nucleic acid molecule.
 2. The cured tobacco material of claim 1, wherein the cured tobacco material is selected from the group consisting of air-cured tobacco material, fire-cured tobacco material, sun-cured tobacco material, and flue-cured tobacco material.
 3. The cured tobacco material of claim 1, wherein the cured tobacco material is from a tobacco type selected from the group consisting of Burley tobacco, Maryland tobacco, bright tobacco, Virginia tobacco, Oriental tobacco, Turkish tobacco, and Galpão tobacco.
 4. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of CC 13, CC 27, CC 33, CC35, CC 37, CC 65, CC 67, CC 700, GF 318, GL 338, GL 368, GL 939, K 346, K 399, K326, NC 102, NC 196, NC 291, NC 297, NC 299, NC 471, NC 55, NC 606, NC 71, NC 72, NC 92, PVH 1118, PVH 1452, PVH 2110, SPEIGHT 168, SPEIGHT 220, SPEIGHT 225, SPEIGHT 227, and SPEIGHT
 236. 5. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Coker 48, Coker 176, Coker 371-Gold, Coker 319, Coker 347, GL 939, K 149, K326, K 340, K 346, K 358, K 394, K 399, K 730, NC 27NF, NC 37NF, NC 55, NC 60, NC 71, NC 72, NC 82, NC 95, NC 297, NC 606, NC 729, NC 2326, McNair 373, McNair 944, Ox 207, Ox 414 NF, Reams 126, Reams 713, Reams 744, RG 8, RG 11, RG 13, RG 17, RG 22, RG 81, RG H4, RG H51, Speight H-20, Speight G-28, Speight G-58, Speight G-70, Speight G-108, Speight G-111, Speight G-117, Speight 168, Speight 179, Speight NF-3, Va 116, and Va
 182. 6. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of K326, K346, and NC196.
 7. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Clay 402, Clay 403, Clay 502, Ky 14, Ky 907, Ky 910, Ky 8959, NC 2, NC 3, NC 4, NC 5, NC 2000, TN 86, TN 90, TN 97, R 610, R 630, R 711, R 712, NCBH 129, HB4488PLC, PD 7319LC, Bu 21×Ky 10, HBO4P, Ky 14×L 8, Kt 200, Newton 98, Pedigo 561, Pf561 and Va
 509. 8. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of TN 90, KT 209, KT 206, KT212, and HB
 4488. 9. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Md 10, Md 40, Md 201, Md 609, Md 872 and Md
 341. 10. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Sumatra, Jatim, Dominican Cubano, Besuki, One sucker, Green River, Virginia sun-cured, and Paraguan Passado.
 11. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Narrow Leaf Madole, Improved Madole, Tom Rosson Madole, Newton's VH Madole, Little Crittenden, Green Wood, Little Wood, Small Stalk Black Mammoth, DT 508, DT 518, DT 592, KY 171, DF 911, DF 485, TN D94, TN D950, VA 309, and VA
 359. 12. The cured tobacco material of claim 1, wherein the cured tobacco material comprises tobacco plant tissue from a tobacco variety selected from the group consisting of Izmir, Katerini, Samsun, Basma and Krumovgrad, Trabzon, Thesalian, Tasova, Sinop, Izmit, Hendek, Edirne, Semdinli, Adiyanman, Yayladag, Iskenderun, Duzce, Macedonian, Mavra, Prilep, Bafra, Bursa, Bucak, Bitlis, and Balikesir.
 13. The cured tobacco material of claim 1, wherein said heterologous nucleic acid molecule encodes at least one axillary bud-degrading product.
 14. The cured tobacco material of claim 13, wherein said at least one axillary bud-degrading product is selected from the group consisting of a microRNA, a small interfering RNA, and a polypeptide.
 15. The cured tobacco material of claim 14, wherein said polypeptide comprises an amino acid sequence at least 70% identical or similar to an amino acid sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, 48, 50, 52, 54, 58, 60, 62, 68, 70, 72, 74, 76, 78, 80, 82, 161-185, 187, 189, 191, 193, 195, 197, 199, 201, 203, 206, 208, 210, 212, 214, 216, 218, 220, 222, 224, 229, 231, 233, 235, 237, 239, 241, 243, 245, 247, 249, 251, 253, and
 255. 16. The cured tobacco material of claim 14, wherein said small RNA molecule comprises at least 18 contiguous nucleotides identical or complementary to a polynucleotide selected from the group consisting of SEQ ID NOs: 83-101.
 17. A bale of tobacco comprising the cured tobacco material of claim
 1. 18. The cured tobacco material of claim 1, wherein the cured tobacco material comprises cured tobacco leaves.
 19. The cured tobacco material of claim 18, wherein a tobacco product comprises the cured tobacco leaves.
 20. The cured tobacco material of claim 19, wherein the tobacco product is selected from the group consisting of a cigarette, a kretek, a bidi cigarette, a cigar, a cigarillo, a non-ventilated cigarette, a vented recess filter cigarette, pipe tobacco, snuff, chewing tobacco, moist smokeless tobacco, fine cut chewing tobacco, long cut chewing tobacco, and pouched chewing tobacco product. 